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ABSTRACT 
This work is an account of the phytochemical analysis of two genera, Vernonia and Vepris 
which are used as remedies for illness by the Kalenjin community of Kenya.  Species of 
Vernonia are known to yield sesquiterpene lactones, which typify the genus whereas Vepris 
is rich in alkaloids and limonoids which have a wide range of biological activities.  The 
species studied in this work were Vernonia auriculifera, Vernonia urticifolia, Vepris 
glomerata and Vepris uguenensis.  
Phytochemical studies revealed a range of compounds being present in the four species.  
From Vernonia, triterpenoids, a sesquiterpene amine, a carotenoid and a polyene were 
isolated.  This was the first account of a sesquiterpene amine from a plant species and the 
first account of the novel polyene.  The triterpenoids showed moderate antibacterial activity, 
with β-amyrin acetate and oleanolic acid being effective at decreasing adhesion of selected 
gram-negative and gram-positive bacteria.  Lutein and urticifolene showed good 
antibacterial activity against Enterococcus feacium and Pseudomonas aeruginosa.  
In Vepris, a range of compounds were isolated, belonging to the furoquinoline alkaloids, 
coumarins, flavonoids, cinnamic acid derivatives, lignins, cinnamaldehydes, triterpenoids 
and limonoids.  Five new compounds; a cinnamaldehyde derivative (glomeral), two 
flavonoids (veprisinol, uguenenprenol) and two A, D-seco-limonoids (uguenensene and 
uguenensone) were amongst the compounds isolated.  Antibacterial studies showed that 
glomeral inhibited the growth of Staphylococcus aureus and Shigella dysentrieae at low 
concentrations (MIC of 2 µg mL-1 and 0.4 µg mL-1 respectively).  Antioxidant assays of 
several compounds revealed that, veprisinol, isohaplopine-3,3’-dimethylallyl ether, 
uguenenprenol and 7-O-methylaromadenrin are good antioxidant agents. The limonoids 
isolated from Vepris uguenensis also make up an interesting biogenetic relationship. 
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Structural elucidation was carried out by 1D and 2D NMR spectroscopy in conjuction with 
mass spectrometry, infrared, ultraviolet and circular dichroism analysis where applicable. 
Biological assays were carried out using standard methods at laboratories in the University 
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SUMMARY OF COMPOUNDS ISOLATED 
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ABBREVIATIONS 
ANOVA analysis of variance 
1H NMR  proton nuclear magnetic resonance spectroscopy 
13C NMR  C-13 nuclear magnetic resonance spectroscopy 
COSY correlated spectroscopy 
DEPT  distortionless enhancement by polarization transfer 
DPPH 2,2-diphenyl-1-picrylhydrazyl 
EIMS  electron-impact mass spectroscopy 
FRAP ferric reducing antioxidant potential 
HMBC heteronuclear multiple bond coherence 
HSQC  heteronuclear single quantum coherence 
HRMS high-resolution mass spectrometry 
MS   mass spectrometry 
NOESY  nuclear overhauser effect spectroscopy 
RSA  radical scavenging activity 
UV  ultraviolet 
Ac  acetate 
br  broad resonance 
m  multiplet 
c  concentration 
cc   column chromatography 
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d   doublet 
dd  double doublet 
Hz  Hertz 
Me    methyl 
s  singlet 
t  triplet 
IR  infrared 
Mp  melting point 
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CHAPTER ONE 
INTRODUCTION 
1.1 Introduction to the genus Vernonia 
1.1.1 Phylogeny 
Vernonia is one of the largest genera of flowering plants in the Asteraceae family, which 
includes more than 1500 species distributed widely in the tropical and sub-tropical region of 
Africa, Asia and America.  It has two major centres of origin, South America and tropical 
Africa, with approximately five hundred species found in Africa and Asia, three hundred in 
Mexico, Central and South America and sixteen in the USA.  Of the five-hundred species 
found in Africa, thirty are endemic to Kenya (Beentje, 1994; Oketch-Rabah et al., 1997). 
 
It has been difficult to establish relationships within the Vernonia species due to their 
overlapping characteristics.  While the original family members (Barnadesioideae) are 
found in South America, the tribe Vernonieae is believed to have originated in Madagascar 
and its sister tribe, the Liabeae is found in America.  This difficulty in classifying the 
species gave rise to the nickname, the ‘evil tribe’ (Funk et al., 2005).  As such there has 
been no phylogeny proposed for the tribe Vernonieae and only a few relationships had been 
suggested even among the best known species (Jones, 1977).  The tribe Vernonieae has been 
traditionally placed in the subfamily Cichorioideae (Funk et al., 2005).  In a recent study it 
was found that the species in America were derived from those of Europe, Asia and Africa 
(Keeley et al., 2007). 
 
The leaves of Vernonia are bright green, with a serrated edge and a light yellow central vein.  
They are alternate with each other along the stems, getting smaller towards the tip.  The 
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stems are upright and stiff and branch sparingly to about 1.2 m high.  The flowers are light 
to dark purple and are grouped in dense clusters at the tip of the stems.  The seeds are very 
light in weight and hairy (Olorode, 1984).  The majority of these plants are used as 
ornaments and vegetables, while others are considered as weeds in agriculture.  The 
vegetables have a bitter taste, hence the name “the bitter genus Vernonia” (Aliyu et al., 
2011). 
1.1.2 Ethnobotanical information of Vernonia species 
An ethnomedical survey of Vernonia species (Table 1) revealed widespread and diverse 
medical usage.  Generally these species are used in the treatment of infectious and parasitic 
diseases.  The infectious diseases ranged from those affecting the skin to those of the 
stomach (gastrointestinal infections).  Other major applications include treatment of 
bacterial infections, gynaecological diseases and complications, respiratory diseases, 
diabetes, urinary tract infections and venereal diseases.  Parasitic diseases include malaria, 
worm infection, amoebiasis and schistomiasis.  Some species are also used as antivenom 
against snakebites and insect bites.   
 
Of the Vernonia species, V. amygdalina appears to be the most widely used.  The leaves are 
the most commonly used plant part and is prepared as a decoction.  In some cases a 
decoction of the whole plant is prepared.  The method of preparation depends on the 
application, for example, a mixture of the root and leaf decoction is drunk to treat 
gastrointestinal diseases and as an antipyretic and the leaves soaked in alcohol is drunk to 
treat diabetes mellitus.  The traditional medicinal applications of members of the genus are 
illustrated in Table 1.  
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Table 1 Species of Vernonia used in traditional medicine 
Plant species Plant 
 part 
Traditional use References 
V. ambigua Whole 
 plant 
antimalarial Builders et al., 2011 








gynaecological diseases and 
complications, infertility, 
antibacterial, antifungal and 
antivenom (snake bite) 
Akah and Okafor 1992; 
Akah and Ekekwe 1995;  
Yeap et al., 2010; 
Huffman et al., 1993 
 
stems anti-HIV, antiviral and anti-
amoebic 






antimalarial, anthelmintic,  
antibacterial and antiviral 
Yeap et al., 2010; 
Erasto et al., 2006 
roots venereal diseases and  
gynaecological  
complications 
Yeap et al., 2010; 
Geissler et al., 2002 
V. anthelmintica seeds anthelmintic, respiratory  
diseases, gastrointestinal  
diseases and complications,  
diuretic, anti-inflammatory, 
kidney protection and anti-
ulcer  
Otari et al., 2010 
V. branchycalyx roots gastrointestinal  
complication 
Oketch-Rabah et al., 1997 
V. cinerea leaves 
and 
roots 




gastrointestinal diseases,  
gynaecological diseases,  
respiratory diseases, antidote  
and urinary tract diseases  
Deborah et al., 1992; 
Khare, 2007; 
Marita et al., 1999; 
Misra et al., 1993 
V. colorata leaves dermatological infections,  
respiratory diseases,  
antidiabetic, gastrointestinal  
diseases, antipyretic, 
antiviral (hepatitis)  and 
venereal diseases 
Cioffi et al., 2004; 
 Rabe et al., 2002; 
Sy et al., 2004 
V. condensata leaves analgesic, anti-ulcer, anti- 
diarrhoea, gastrointestinal  
Frutuoso et al., 1994; 
Pereira et al., 1994 
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diseases,  liver protection  
and antivenom (snakebites) 
V. conferta bark anti-diarrhoea (bloody)  Aliyu et al., 2011 
V. cumingiana ns antirheumatic arthritis, 
antiviral, bone and muscular 
injury,  
respiratory diseases,   
antimalarial, and dental 
diseases 
Lin et al., 1985; 
Zhonghuabencao, 1999 
V. ferruginea ns anti-inflammatory remedies Malafronte et al., 2009 
V. galamensis leaves antidiabetic (mellitus) and 
gastrointestinal diseases 
Chhabra et al., 1989 
V. guineensis ns antidote to poison, 
aphrodisiac,  jaundice, anti 
malarial and prostatitis 
Tchinda et al., 2002 
V. jugalis bark anti-diarrhoea (bloody) Aliyu et al., 2011 
V. kotschyana roots abdominal pains, respiratory 
diseases including TB, 
antibacterial, dermatological 
infections, gastrointestinal 
disorder,  analgesic, 
antiparasitic,  antiprotozoa 
and  anti-ulcers  
Sanogo et al., 1998; 
Nergard et al., 2004 
V. mapirensis ns anti-inflammatory Morales-Escobar et al., 2007 
V. nigritiana root diuretic, gastrointestinal  
infections, emetic,  
antipyretic and anthelmintic 
Aliyu et al., 2011 
V. nudicaulis whole 
plant 
venereal diseases Aliyu et al., 2011 
V. pachyclada ns dermatological injury Williams et al., 2005 






Chiu and Chang, 1987 
 
leaves antiamoebic, anthelmintic,  
antiviral,  respiratory tract  
infection, gastrointestinal  
infections and dermatitis 
Gani, 1998 
roots gastrointestinal infections,  
respiratory tract infection  
and colic 
Gani, 1998 
flowers  eye problem, antipyretic  
and antirheumatic 
Mollik et al., 2010 
Gani, 1998 
seeds anthelmintic,  
gastrointestinal disorder,  
urinary tract infection 
 and dermatological  
infection  
Gani, 1998 
V. polytricholepis ns antipyretic  and respiratory 
 infections 
Aliyu et al., 2011 
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V. potamophila leaves anticancer and skin 
infection  
Babady-bila et al., 2003 
V. saligna ns respiratory tract infections  
 and gynaecological  
complications 
Huang et al., 2003 
V. scorpioides leaves dermatological infection  
(diabetic lesions) and anti-
ulcer  
Pagno et al., 2006; 
Buskuhl et al., 2010 
V. trichoclada ns anti-inflammatory Morales-Escobar et al., 2007 
V. tweediana ns respiratory tract diseases Zanon et al., 2008 
Key: ns-not specified 
1.1.3 Biological activity of extracts from Vernonia species  
Biological activities of Vernonia extracts have been extensively studied as far back as 1969.  
The variety of secondary metabolites extracted from Vernonia species, explains the diversity 
of their biological activities.  Among the diverse biological activities, antibacterial studies 
are the most reported.  Antibacterial activity was found to be common to all species in all 
extracts followed by conditions associated with pain, fever and inflammation and 
antiparasitic activity, including malaria, schistomiasis and leishmania. Antibacterial 
compounds are mainly lipophilic and will partition from an aqueous phase into bacterial 
membrane structures, causing expansion of the membranes, increased fluidity, disordering 
of the membrane structure and inhibition of membrane embedded enzymes (Sikkema et al., 
1995).  Antifungal activity is also reported in five of the Vernonia species, while antiviral is 
not commonly reported in the Vernonia with only one report in the ethanol extract of the 
fruit of V. amagdalina. 
 
Seven species have been associated with being active in assays against pain, fever or 
inflammation, which includes conditions such as arthritis and gastritis.  In rural areas where 
access to healthcare is not readily available, people rely on these extracts for common pain 
relief, inflammation and fever.  Four of the nineteen species have also been reported to have 
some form of antiparasitic activity, either antiplasmodial, antileishmanial, antischistomatic, 
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anti-amoebic or antihelmintic.  These are mainly reported for the polar extracts such as the 
aqueous and methanol extracts with few reports being in the chloroform or hexane extract. 
 
Beside the antibacterial, antiparasitic and conditions associated with pain, inflammation and 
fever, extracts of these plants have also shown other activities such as antidiabetic, 
antioxidant, anticancer, antiulcer, immunomodulatory, pesticidal and insecticidal activity.  
 
The most extensively studied plant among all the Vernonia species is V. amygdalina, 
reported to possess several pharmacological activities such as antidiabetic, antibacterial, 
antimalarial, antifungal, antioxidant, liver protection and cytotoxic effects (Table 2).  The 
biological activities of Vernonia species that have been studied and documented are listed in 
table 2.  
Table 2: Biological activities of extracts from Vernonia   
Plant species Biological activity  Extract  Reference (s) 
V. ambigua antibacterial ethanola and chloroforma  Aliyu et al., 2011 
antiparasitic  
(antiplasmodial) 
and antioxidant  
waterwp Builders et al.,2011 
 
 
V. amagdalina antibacterial waterr and ethanolicl Ogbulie et al., 2007 
bactericidal  (oral 
bacterial) 
cold waters, b, p Rotimi and Mosadomi,  1987 
antifungal watersb,r and methanolsb,r Nduagu et al., 2008 
antiviral  ethanolfr Vlietinck et al., 1995 
antiparasitic 
(antiamoebic) 
methanoll and waterl 
 
Moundipa et al., 2005 
(antileishamanial) chloroforml and ethanoll 
 
Carvalho and Ferreira 2001 
(antischistomiasis) petroleum etherl  
and  ethanolicl 
Adedapo et al., 2007 
(anthelmintic) water l,s,r Adedapo et al., 2007 
(antiplasmodial) ethanolicl,r Abosi and Raseroka, 2003 
analgesic and 
antipyretic 
waterl and ethanolr Tekobo et al., 2002 
anti-inflammatory  waterl Iroanya et al., 2010 
antioxidant 
 
ethanolr and methanolns Yeap et al., 2010 
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cytotoxic cold waterwp Vlietinck et al., 1995 
anticancer cold waterl Izevbigie et al., 2003 
antidiabetic waterwp and isopropanolwp Erasto et al., 2006 
Taiwo et al., 2009 
liver protective  methanoll and waterl  Adesanoye and Farombi, 2009 





Ohigashi et al., 1991 
 









Otari et al., 2010 
 
anti-inflammatory waterns-ethanolicns  
 
Parekh and Chanda 2008 
antidiabetic and  
antihyperglycemic 
EtOAc:isopropanol (1:1)sd  Fatima et al., 2010 
V. blumeoides antibacterial ethanola and chloroforma  Aliyu et al., 2011 




l Oketch-Rabah et al., 1998 
(antimalarial) waterl Oketch-Rabah et al., 1997 
V. brasiliana (antiplasmodial) hexanel Alves et al., 1997 
V. cinerea antibacterial benzenel  
 
Gupta et al., 2003a; 
Latha et al., 2009 
antifungal methanola 
 
Latha et al., 2009 
antioxidant methanola  Kumar et al., 2009; 
Latha et al., 2009 
anti-inflammatory alcoholicfl Latha et al., 1998 
antipyretic methanolwp Gupta et al., 2003b 
analgesic and 
antipyretic 
chloroforml, methanoll  
and etherl 
Mazumder et al., 2003 
immunomodulatory methanolicns Pratheeshkumar and  
Kuttan,  2010 
V. colorota antibacterial,   
antiparasitic  
(antiplasmodial), 





Chukwujekwu et al., 2009;  
Cioffi et al., 2004 
antidiabetic aqueousl  Sy et al., 2004 
V. condensata analgesic,  
antigastritis,   
antiulcer and  
antinociceptive 
acetone-EtOH-EtOAcl  Frutuoso et al., 1994;  
Sanogo et al., 1996;  
Risso et al., 2010 
V. glabra antifungal ns Gundidza, 1986 
V. hymenolepis tumor inhibitory  
activity 
alcoholicl  Kupchan et al., 1969 
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V. karaguensis antibacterial and 
 antileukaemic  
Ns Mungarulire,1993;  
Taiwo et al., 1999  
V. kotchyana antibacterial,  
analgesic, 
antigastritis and  
antiulcer 
aqueous/n-butanolr 
extract and acidicr  
Frutuoso et al., 1994; 
Germano et al., 1996;  
Sanogo et al., 1996, 1998 
V. oocephala antibacterial ethanol/chloroforma  Aliyu et al., 2011 
V. paltula antibacterial,  
antifungal, 
anti-inflammatory 
and antipyretic  
ethanolicwp, fl, fr, t, l  Chiu and Chang 1987 
 
V. polyanthes antiulcerogenic methanolica and 
chloroforma  
Barbastefano et al., 2007 
V. pogosperma antibacterial Ns Tripathi et al., 1981 
V. scorpioides cytotoxic effects  
(anti-tumor) 
dichloromethanel  Pagno et al., 2006 
bactericidal and  
fungicidal  
chloroforml and hexanel  Buskuhl et al., 2010; 
Freire et al., 1996 
V. thomsoniana antibacterial and  
antileukaemic   
Ns Mungarulire, 1993;  
Taiwo et al., 1999  
Key: superscripts, a = aerial parts, fr = fruits, fl = flowers l = leaves, ns = not specified,  
r = roots, s = stems, sb = stem bark, sd = seeds, wp = whole plant  
 
1.1.4 A phytochemical review of the triterpenoids from Vernonia species 
Phytochemical compounds previously isolated in Vernonia include sesquiterpene lactones, 
triterpenoids, flavonoids, coumarins, steroidal glycosides and carotenoids.  Although 
sesquiterpene lactones are the main chemotaxonomic markers of this genus, none were 
isolated in this work.  To date, there are approximately twenty-six publications on 
triterpenoids in Vernonia species (Scifinder, 2009).  The isolation of tritepenoids from this 
genus is recorded to have begun as early as 1979, where the tetracyclic triterpenoid, 
fasciculatol was isolated from V. fasciculata.  This remains to be the only tetracyclic 
triterpenoid isolated from Vernonia and all other phytochemical studies have reported 
pentacyclic triterpenoids.  In this study, triterpenoids were the main compounds isolated 
from the Vernonia species investigated and as a result the literature review which follows 
focuses on the triterpenoids in Vernonia. 
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1.1.4.1 A Brief Introduction to Triterpenoids 
Triterpenoids are compounds based on a 30-carbon skeleton consisting of five six-
membered rings or four six-membered rings and a five-membered ring.  They are a wide-
spread group of natural terpenoids and are found in most plants.  In Vernonia, seven classes 
of triterpenoids have been isolated and reported, of which five are closely related and posses 
five six-membered rings in their basic skeleton (oleanane, ursane, taraxarene, friedelane and 
friedoursane), the other two classes being  lupane (four six membered rings and a five-
membered ring) and a tetracyclic triterpenoid.  
Triterpenoids are produced by rearrangement of squalene epoxide (10) which is believed to 
have been biosynthesized by the mevalonate pathway, but recently the route via the 
deoxyxylulose phosphate pathway (DXP (4)) is reported to be more widely accepted 
(Dewick, 2006).  The main precursor of terpenoids is the isoprene unit, which is formed via 
isopentyl diphosphate (IPP) (1) and dimethylallyl diphosphate (DMAPP) (2), the latter 














Scheme 1: Isomerisation of IPP to DMAPP (Dewick, 2006) 
These units may be derived from mevalonic acid (MVA) (3) or deoxyxylulose phosphate 
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In plants, the enzymes from the mevalonate pathway are found in the cytosol, therefore 
triterpenoids and steroids (cytosolic products) are thought to be formed through this 
pathway, whereas in the deoxyxylulose phosphate (4), the enzymes are found mainly in the 
chloroplasts where the other terpenoids are derived (Dewick, 2006).  IPP (1) isomerises to 
DMAPP (2) via the isomerase enzyme which stereospecifically removes the pro-R proton 
from C-2 and incorporates a proton from water onto C-4.  Although the isomerisation 
reaction of IPP (1) to DMAPP (2) is reversible, the equilibrium favours the formation of 
DMAPP (2) (Scheme 1). 
 
When the phosphate (a good leaving group) of DMAPP (2) leaves, it yields an allylic 
carbocation that is stabilised by charge delocalisation, therefore making it electrophilic.  IPP 
(1) on the other hand is a strong nucleophile due to the terminal double bond.  This differing 
reactivity of DMAPP (2) and IPP (1) forms the basis of terpenoid biosynthesis in the linkage 
of isoprene units in a head-to-tail manner (Dewick, 2006; Zulak and Bohlmann, 2010).  
 
The combination of DMAPP (2) and IPP (1) through prenyl transferase mediation, results in 
the formation of geranyl diphosphate (GPP) (5), the fundamental precursor for 
monoterpenoid (C10) compounds.  This involves ionisation of DMAPP (2) to the allylic 
cation to which the double bond of IPP (1) adds, followed by the stereochemical loss of the 
pro-R proton.  GPP (5) possesses the reactive allyl diphosphate group and the reaction 
mediated by prenyl tranferase continues by addition of an IPP (1) unit to the geranyl cation 
which results in the formation of farnesyl diphosphate (FPP) (6), the sesquiterpenoid (C15) 
and geranyl geranyl diphosphate (GGPP) (7), the diterpenoid precursor (Scheme 2).  
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Triterpenoids are formed by joining two FPP (6) units in a tail-to-tail manner to yield the 
hydrocarbon squalene (9), formed from the precursor presqualene diphosphate (8) by a 
reaction that follows a different path from the previous condensation reactions.  It was 
difficult to formulate the mechanism for the formation of squalene (9) however it was 
resolved when presqualene diphosphate (8) was isolated from rat liver (Dewick, 2006).  The 
formation of presqualene diphosphate (8) (Scheme 3) is by an attack of the ∆2 double bond 
of one FPP (6) molecule on the farnesyl cation (formed by enzymatic ionisation of the 
second FPP (6) molecule).  The resulting tertiary cation is discharged by loss of a proton 
with the formation of a cyclopropane ring to yield presqualene diphosphate (8).  This is 
followed by loss of diphosphate to form an unstable primary cation that undergoes 
rearrangement to generate a more favourable secondary carbocation and less strained 
cyclobutane ring.  Bond cleavage produces an allylic cation, stabilised by charge 
delocalisation, which is quenched by attack of a hydride ion from NADPH to form squalene 
(9), an important precursor of cyclic triterpenoids (Scheme 3).  
 

























Scheme 2: Formation of triterpenoid precursors GPP, FPP and GGPP (Dewick, 2006, 
Zulak and Bohlmann, 2010). 
 





















loss of proton with formation
of cyclopropane ring
bond cleavage yields alkene
and stable allylic cation
NADPH
cation quenched




Scheme 3: Formation of squalene (Dewick, 2006)   
Cyclisation of squalene (9) is possible through the intermediate squalene-2,3-oxide (10) 
which is produced in a reaction catalysed by a flavoprotein in the presence of O2 and 
NADPH cofactors, resulting in the epoxidation of the terminal double bond in squalene 
(10). 
If squalene-2,3-oxide (10) is folded onto a chair-chair-chair-boat conformation on the 
enzyme surface, the transient dammarenyl cation (11) is produced through a series of 
cyclisations followed by a sequence of Wagner-Meerwein rearrangements of 1,2-hydride 
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and 1,2-methyl migrations to form the C-20 epimers, euphol (12) and tirucallol (13) 
























Scheme 4: Formation of limonoid and triterpenoid precursors (Dewick, 2006)  






Fasciculatol (14) is the only reported tetracyclic triterpenoid from Vernonia being isolated in 
V. fasciculata and is formed by the oxidation and then cyclisation of the side chain of 
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euphol (12)/tirucallol (13).  Reduction at position 12 leads to the formation of a double bond 
with the concomitant loss of the methyl group at position 13. 
1.1.4.3 Lupane triterpenoids 
The lupane triterpenoids are characterised by four six-membered rings with a fifth five-
membered ring to which an isopropyl group is attached.  Five lupane triterpenoids have 
been isolated from Vernonia species, all with the same basic skeleton which is formed by a 
1,2-alkyl shift in the dammarenyl cation (11) resulting in the bacharenyl cation (15) 
followed by cyclisation onto ring D leading to a lupenyl cation (16) which ultimately leads 
to lupeol (17) through the loss of a proton (Scheme 5).  All Vernonia species except for V. 
cinerea, V. fasciciulata and V. saligna were found to contain lupeol (17).  V. cinerea and V. 
saligna although not containing lupeol did contain derivatives of lupeol, lupenyl acetate (18) 



































































  R 
17 lupeol OH 
18 lupenyl acetate OAc 
19 lupenyl palmitate OCO(CH2)14CH3 
20 lupenyl-20(29)en-3β-O-D-glucoside O-Glu 
21 18,19-dehydrolupenyl acetate OAc 
  
 





















Scheme 5: Formation of lupeol (Dewick, 2006) 
1.1.4.4 Oleanane triterpenoids 
Another widely distributed triterpenoid in Vernonia is the oleanane triterpenoid, β-amyrin 
(23), being found in all Vernonia species except V. arkansana, V. chunii, V. fasciculata and 
V. potamophilia, however V. chunii did contain oleanolic acid (27).  V. mollissima and V. 
patula contained β-amyrin acetate (24), while V. saligna and V. patula contained β-amyrin 
palmitate (25) and β-amyrin benzoate (26) respectively.  
 
The oleanane triterpenoids are characterised by five six-membered rings with a double bond 
at ∆12 and two methyl groups situated on the same carbon at position 20.  They are formed 
by ring expansion in the lupenyl cation (16) by a Wagner-Meerwein rearrangement (a 1,2-
alkyl shift) leading to the formation of the oleanyl cation (22) (Scheme 6), which is then 
discharged by hydride migration and loss of a proton to form β-amyrin (23).  Acetylation, 
aliphatic esterification and aromatic esterification has led to the other three β-amyrin 
 
P a g e  | 17 
derivatives (24-26).  Oleanolic acid (27) is formed through the oxidation of the methyl 
group at C-17. 
 
  R1 R2 
23 β-amyrin OH CH3 
24 β-amyrin acetate OAc CH3 
25 β-amyrin palmitate OCO(CH2)14CH3 CH3 
26 β-amyrin benzoate OCOPh CH3 





































Lupenyl cation (18) oleanyl cation (22) R = OH β−amyrin (23)





Scheme 6: Formation of oleanyl cation precursor (Dewick, 2006).   
1.1.4.5 Taraxarane and Ursane triterpenoids 
The difference between the oleanane triterpenoids and the taraxarane and ursane 
triterpenoids lies in the position of the methyl groups on ring E.  In the oleananes there are 
two methyl groups at C-20 whereas in the taraxaranes and the ursanes, a methyl group 
migrates from the oleanyl cation (22), resulting in the methyl groups being on adjacent 
carbon atoms, C-19 and C-20.  The ursane, α-amyrin (29) is the third most common 
triterpenoid apart from lupeol (17) and β-amyrin (23), being found in ten of the sixteen 
Vernonia species studied phytochemically.  The three compounds, lupeol (17), β-amyrin 
(23) and α-amyrin (29) form a suite of compounds found in nine of the sixteen species of 
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In addition, α-amyrin acetate (30) is found in V. patula and together with α-amyrin (29) in 
V. saligna.  Taraxasterol (32) is found together with α-amyrin (29) in V. incana and V. 
cognata, while V. chalybaea contains α-amyrin (29), pseudotaraxasteryl acetate (31) and 
taraxasteryl acetate (33) and V. cinerea contains α-amyrin (29), α-amyrin acetate (30), 24-
hydroxytaraxa-14-ene (34), 3β-acetoxyurs-13(18)-ene (35) and 3β-acetoxyurs-19-ene (36). 
Between the taraxaranes and the ursanes, there is a difference in the position of the double 
bond, which is brought about by the way in which the taraxasteryl cation (28) is quenched 
by the loss of the hydrogen with concomitant hydrogen migrations.  In α-amyrin (29) and 
the rest of the ursanes, the H-12 proton is lost and the double bond is formed at ∆12.  














1,2-methyl shif t 1,2-hydride shift
α−amyrin R = OH (29)




























Scheme 7: Formation of taraxasteryl cation and the ursane class triterpenoids 
In the taraxaranes, the proton at either C-21 or C-30 is lost, leading to a double bond at 
either ∆20 (31) or at 20(30) leading to taraxasterol (32) with acetylation of 32 resulting in 33 
(Scheme 8).  
 
It is highly likely that the compound classified as a taraxarene (34) does not belong in this 
class and should be grouped with other compounds with a double bond at ∆14 resulting from 
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the loss of a proton at C-15 in the oleanyl cation (22) with hydride migrations quenching the 






R= OH, taraxasterol (32)


































































































Scheme 8: Formation of taraxastane class triterpenoids from taraxasteryl cation  
 
Compounds 35 and 36 have double  bonds in positions different to the ursanes or the 
taraxaranes, 35 has a double bond between C-13 and C-18 and 36 has a double bond at ∆19 
and is more likely to be associated with the taraxaranes as the loss of the proton occurs 
adjacent to the C-20 cation, just as that in 31. 
 



























































3β -acetoxyurs-13(18)-ene (35) 3β-acetoxyurs-19-ene (36)  
1.1.4.6 Friedoursane triterpenoids 
Unlike the cases where the double bond at ∆14 and 13(18) were not given their own 
classification, those with a double bond at the ∆7 position are classified as friedoursane 
triterpenoids as in bauerenyl acetate (37) isolated from V. patula.  They come about by loss 
of a proton at C-7 with methyl and hydrogen shifts quenching the cation in the taraxasteryl 




































bauerenyl acetate (37)  
Scheme 9: Formation of bauerenyl acetate from taraxasteryl cation  
1.1.4.7 The Friedelane triterpernoids 
The Friedelane triterpenoids, 3β-friedelanol (38) and friedelin (39) are found in V. patula 
while friedelin (39) alone is found in V. chalybaea and V. saligna.  The friedelane 
triterpenoids are characterised by methyl groups at C-4, C-5, C-9 and C-13, in addition to 
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those at C-14, C-17 and C-20, which differ to the oleanane triterpenoids which have two 
methyl groups at C-4 and a methyl group at C-10 instead of C-9 and a proton at C-13 
instead of the methyl group.  This difference arises from the origin of the methyl migration 
being from the methyl group at C-4 resulting in a series of methyl and hydrogen migrations 
to quench the oleanyl cation (22) (Scheme 10).  Friedelin (39) is brought about by the action 
of an oxidoreductase oxidising the 3β-hydroxyl group of 3β-friedelanol (38) to a ketone 





























































Scheme 10: Formation of friedelane triterpenoids from the oleanyl cation (Corsino et 
al., 2000) 
The species of Vernonia from which these compounds have been isolated, including the 
parts of the plant that contained them are given in Table 3.  The table revealed that lupeol 
(17), α-amyrin (23) and β-amyrin (29) were common to several species.  V. paltula had the 
highest number of triterpenoids followed by V. saligna and V. chalybaea. V. fasciculata and 
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Table 3: Tritepenoids contained in the different Vernonia species  





 Bohlmann et al., 1981 
 V. brasiliana 17
l , 23l  Alves et al., 1997 
V. chamaedrys  17
fl,s, 23fl,s, 29fl,s Catalán et al., 1988 
V. chalybaea 17
a, 18a, 23a,  29a,  31a 33a, 39a da Costa et al., 2008 
V. chunii 17
ns, 27ns  Yuan et al., 2008 
V. cinerea 18
r, 23r, 29r, 30r, 34r, 35r, 36r  Misra et al., 1984a, 1984b, 1993 
V. cognata 17
fr,l,  23fr,l,  29fr,l, 32fr,l  Bardon et al., 1988b 
V. fasciculata 14
l
 Narain, 1979 
V. incana 17
l, fl,  23l, fl, 29l ,fl , 32 l, fl Bardón et al., 1990 
V. mollissima 17
a, 23a, 24a, 29a  Catalán and Iglesias, 1986 
V. nitidula 17
fl,l, 23fl,l, 29fl,l  Bardon et al., 1988a 
V. patula 17
ns, 18ns, 19a,23ns24ns,26ns,  
30
a, 37wp, 38wp, 39wp 
 
Liang and Min, 2003;  
Liang et al., 2010 
V. potamophilia 17
l
 Babady-Bila et al., 2003 
V. saligna 19





Huang and Liu, 2004 
V. squamulosa 17
a
 , 23a, 29a Catalán and Iglesias, 1986 
V. tweediana 17
l , 23l, 29l  Zanon et al., 2008 
Key: superscripts, a = aerial parts, fl = flowers, fr = fruits, l = leaves, ns = not specified, 
r = roots, s = stems, wp = whole plant 
 
1.2 Introduction to the genus Vepris  
1.2.1 Phylogeny 
The genus Vepris is a member of the Rutaceae family which consists of one hundred and 
sixty genera.  In the classification proposed by Engler in 1931 and adapted by Schotz in 
1964, this genus was put together with the genera Acronychia, Araliopsis, Casimiroa, 
Halfordia, Hortia, Oriciopsis, Sargentia, Skimmia and Toddalia, as individual sub-tribes of 
the tribe Toddalioliineae, subfamily Toddalioideae (Fernandes et al., 1988).  A more 
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accepted taxonomic grouping of the Rutaceae, which included the genera Acronychia, 
Araliopsis, Diphasia, Oricia, Oriciopsis, Vepris and Teclea within the tribe Aronychia was 
proposed in 1983 by Waterman and Grundon (Fernandes et al., 1988).  Vepris species are 
widely distributed all over the world and their morphology is diverse.  They contain a wide 
range of secondary metabolites, which include limonoids, flavonoids, coumarins, volatile 
oils and alkaloids (Groppo et al., 2008).  
This genus is comprised of eighty species of trees and shrubs, occurring primarily in tropical 
Africa, and the Mascarene Islands, and to a lesser extent in tropical Arabia and Southwest 
India where one species is found (Chaturvedula et al., 2003).  African Vepris species are 
found in Cameroon, Democratic Republic of Congo, Ethiopia, Ghana, Kenya, Madagascar, 
Mauritius, Mozambique, Rwanda, South Africa, Swaziland, Tanzania, Zambia, Zanzibar 
and Zimbabwe (Waterman, 1986).  About sixteen species are endemic to Kenya and thirty 
are found in Madagascar (Louppe et al., 2008).  
Vepris species are plants without prickles and the bark is pale to dark grey and fairly 
smooth.  The leaves are unusually glossy green, large, alternate, fairly smooth and drooping; 
when crushed they give an aromatic scent.  The flowers have short auxiliary heads and are 
greenish; the fruits are drupaceous, smooth and usually contain 2-4 seeds (Cheek et al., 
2009).  
1.2.2. Ethnobotanical use of Vepris species 
Of the eighty Vepris species, only a few have documented use in herbal medicine.  Species 
of this genus are mainly used in the treatment of respiratory infections, dermatological 
infections, as analgesics, antipyretics and for oral health.  The two species used for oral 
health, maintains oral cleanliness by contributing to antimicrobial activity and inhibiting 
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plaque and also by dislodging cariogenic microorganisms when the plant is chewed.  Vepris 
species are also reported to have anti-inflammatory and antimalarial properties (Table 4).  
Table 4 Traditional uses of plants belonging to the genus Vepris 
Plant species Plant part Traditional use Reference (s) 
V. ampody leaves and 
bark 
antimalarial, muscular 
aches  and analgesic 
Randrianarivelojosia et al., 
2003 
V. elliotti leaves aphrodisiac  Poitou et al., 1995 
V. eugenifolia bark liver protection, 
respiratory diseases and 
kidney disorders  
Fratkin, 1996; 
Hedberg et al., 1983 
 
V. glomerata roots  eye infection and 
antimalarial 
Chhabra et al., 1991 
V. heterophylla leaves diuretic and antipyretic Gomes et al., 1983 











heart disease, astringent, 
burns, eye problem, colic, 
anti-diarrhoeic, antiviral, 
antibacterial, antipyretic, 
analgesic,  fortifier, 
antirheumatic, gout,   
stimulant, muscular 
disorder and  
dermatological infection 
Arnold and Gulumian 1984; 
Gurib-Fakim et al., 1996;  
Louppe et al., 2008; 
Poullain et al., 2004; 








Gessler et al., 1994, 1995a, 
1995b 





Arnold and Gulumian 1984; 
Steenkamp, 2003 
 
V. louisii stem bark dermatological diseases  
and antifungal 
Ayafor et al., 1982a 




antirheumatic and itching 
root Anthelmintic 







V. paniculata leaves respiratory infections  Gurib-Fakim et al., 1996 
V. simplifolia bark chest complaint Louppe et al ., 2008 
root muscular problems, 
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antibacterial, venereal 
diseases and  
dermatological infections 
leaf respiratory infection and 
dermatological infections 
fruits dental caries 
twigs dental care  
 
1.2.3. Biological activity of extracts from Vepris species  
The biological activities of the extracts from various Vepris species have not been widely 
investigated and reported.  The few reports are diverse (Table 5) with antimalarial activity 
being the most studied.  Antimalarial activity is reported in the ethanol and chloroform 
extracts of six species and also in the essential oil of Vepris elliotii.  Antibacterial activity is 
reported in two species, Vepris lanceolata and Vepris laendriana, antifungal activity in V. 
laendriana and Vepris heterophylla and antioxidant activity in V. heterophylla, and V. 
lanceolata.  Cytotoxic activity was reported in Vepris punctata to be mild and mainly 
against human colon and ovarian cancer (Chaturvedula et al., 2003).   
Of the Vepris species, V. lanceolata has been studied the most; its leaf and root bark extracts 
were found to possess antiplasmodial activity whilst the aqueous leaf and stem extracts were 
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Table 5 Biological activities of extracts from Vepris species 
Plant species Biological 
activity 
Extract Reference 
V. ampody antimalarial ethanols/chloroforms Rasoanaivo et al., 1999 
V. elliotii antiplasmodial essential oill Ratsimbason et al., 2009 
V. fitoravina antimalarial ethanols/chloroforms Rasoanaivo et al., 1999 
V. glomerata antimalarial aqueousl and  ethanolicl Innocent et al., 2009 
V. heterophylla antifungal and 
antioxidant 
methanoll,t and essential 
oill 
Momeni et al., 2010; 
Aoudou et al., 2010 
V. lanceolata antibacterial hexanes, 
methanol:chloroform(1:1)s, 
methanol:chloroform (1:1)l 
and  methanoll 






Gessler et al., 1994, 1995 
 
 
antioxidant dichloromethanes Poullain et al., 2004 
V. leandriana antibacterial and 
antifungal 
essential oill Rakotondraibe et al., 
2001 
V. macrophylla antimalarial ethanol/chloroforms Rasoanaivo et al., 1999 
V. punctata cytotoxic n-hexane/chloroformw Chaturvedula et al., 2003 
Key: ns = not specified, l = leaves, s = stem, w = wood, t = twigs 
1.2.4. A phytochemical review of Vepris species 
Sixteen species of Vepris have been studied for their phytochemical properties thus far 
(Scifinder, 2009).  Although furoquinoline alkaloids are the most common isolates, acridone 
alkaloids, quinol-2-one alkaloids, indoloquinazoline alkaloids, flavonoids, cinnamic acid 
derivatives, limonoids and terpenoids have also been found.   
The species of Vepris from which these compounds were isolated, including the parts of the 
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Table 6: Compounds isolated from Vepris species 
Species Compounds isolated References 
V. ampody 45
l&br, 46 l&br, 47 l&br,  49 l&br, 54 
l&br
 75
sb,76sb,  77sb,  82l&br,  87l&br 
109
 l&br, 110 l&br  
Kan-Fan et al., 1970; 
 Rasoanaivo et al., 1999 
 
V. bilocularis 48
sb, 49sb , 54ns , 55sb , 65l,63l, 66l, 
67




Govindachari and Sundararajan, 
1961, 1964; Ganguly et al., 
1966; Brader et al., 1996 
V. dainellii 48
l, 49l Dagne et al., 1988 
V. fitoravina 54
l, 79l, 83l, 85l, 86l Koffi et al., 1987 
V. glomerata 48
l, 59l Dagne et al., 1988 
V. heterophylla 49
l, 60l, 61l, 93l, 103l-108l Gomes et al., 1983, 1994 
V. lanceolata 58
l,  59l, 61l, 62l, 95sb,w, 97sb,w, 
99




sb, 43sb, 44tb, 49tb,  52tb, 64sb, 
71




Ayafor et al., 1980, 1981, 
1982a, 1982b, 1982c; Ngadjui et 
al., 1982 
V. macrophylla 54
l, 79l, 83l, 85l, 86l Koffi et al., 1987 
V. pilosa 49
r, 79r, 80r, 88r  Haensel and Cybulski, 1978 
V. punctata 17
w, 18w, 29w, 32w, 48w, 49w, 53w, 
54




Chaturvedula et al., 2003, 2004 
V. reflexa 17




V. stolzii. 17sb, 48sb, 50sb, 64sb,68sb,69sb,70sb  Khalid and waterman, 1982 
V. uguenensis 51
r, 55r, 90r, 96r, 111r, 112r Cheplogoi et al., 2008 
Key: superscripts, a = aerial parts, br = branches, fl = flowers, fr = fruits, l = leaves, r = roots, 
    s = stems, sb = stem bark, tb = tree bark, w = wood, wp = whole plant,  
1.2.4.1. Quinoline alkaloids  
The quinoline alkaloids are found in several Vepris species (Table 6), with two species, 
Vepris dainellii and Vepris glomerata exclusively containing compounds of this class.  
Quinoline alkaloids are nitrogenous compounds based on the benzo[b]pyridine or 1-
azanaphthalene (40) skeleton.  They occur abundantly in the family Rutaceae and have been 
used in the chemotaxanomic classification of many species in the family. These compounds 
are biosynthesized from anthranilic acid (41).  
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The quinoline ring is formed by the condensation of anthranilic acid (41) and malonyl-CoA 
followed by cyclisation via intramolecular amide formation, which results in a heterocyclic 
system with the more stable 4-hydroxy-2-quinolone (42) form.  The other form, the di-enol 





























































Scheme 11: Biosynthesis of 2-quinolone alkaloids (Dewick, 2006) 
The 2-Quinolone alkaloids  
N-methylpreskimmianine (43) and veprisilone (44) have been found in the stem and trunk 
bark of Vepris louisii.  Both these compounds have arisen from the intermediate 42 being 
methylated both at the secondary amine and the hydroxy group at C-4 as well as being 
prenylated at C-3.  Veprisilone (44) is further oxidised in the prenyl ring.   
 













The 4-Quinolone alkaloids 
The 4-quinolones 45-47 have been isolated from Vepris ampody and differ from the 2-
quinolones by the position of the carbonyl which is at C-4.   These compounds arise from 
carbon nucleophiles attacking the C-2 carbonyl group in the quinolodione system, followed 





45 2-(Nona-3’,6’-diene)-4-quinolone (CH2)2CH=CHCH2CH=CHCH2CH3 
46 2-(Nona-9’-ol)-4-quinolone (CH2)8CH2OH 

































Scheme 12: Formation of simple 4-quinoline alkaloids (Dewick, 2006).  
Furanoquinoline alkaloids  
This class of alkaloids possesses three rings; a benzopyridine group consisting of two rings 
to which a furan ring, a third ring, is attached. They are formed from 42 through prenylation, 
cyclisation and then side chain cleavage of the three carbon fragment (Scheme 13).  Various 
hydroxylations and methylations to dictamine (Scheme 13), the simplest known 
furoquinoline alkaloid, results in several substituted furoquinoline alkaloids.  Aromatic 
hydroxylation followed by alkylation leads to skimmianine (48) found in five Vepris 
species, V. bilocularis, V. dainellii, V. glomerata, V. punctata and V. stolzii (Table 6).  
Kokusaginine (49) is found in the Vepris species of ampody, bilocularis, dainellii, 
heterophylla, louisii, pilosa, punctata and reflexa, making it the most common 
furanoquinoline alkaloid, being found in eight species.  Vepris stolzii contains γ-fagarine 
(50) and maculosidine (51) was isolated from Vepris uguenensis.  V. louisii contains 
veprisinium hydrochloride (52) and 4,5,6,7,8-pentamethoxymaculine (53) is found in Vepris 
punctata.  
 



































































dictamineskimmianine (48)  
Scheme 13: Biosynthesis of furanoquinoline alkaloids (Dewick, 2006) 
The methoxylated methylenedioxy furanoquinolines, maculine (54) and flindersiamine (55) 
are found together in V. bilocularis and V. punctata with only one of them, 55 being found 
in V. reflexa and V. uguenensis.  In addition, 5-methoxymaculine (56) and 5,8-
dimethoxymaculine (57), methoxylated at the 5-position as well as the 4- and 8-positions are 
contained along with 54 and 55 in V. punctata.  The introduction of a methylenedioxy group 
at C-6 and C-7 usually arises by cyclisation when a methoxy and hydroxy group are present 
on adjacent carbon atoms.  
 























































The oxidised C-7 O-prenylated anhydroevoxine (58) and evoxine (59) is found in V. 
lanceolata with 59 also being present in V. glomerata.  These compounds are the epoxidised 
and dihydroxylated forms of isoisohaplopine-3,3’-dimethylallyl ether (not isolated 
previously from Vepris species), which probably arises from the O-prenylation at C-7 in γ-
fagarine (50) (Scheme 14). 
V. heterophylla contains a C-5 prenylated furanoquinoline, tecleaverdoornine (60), 
containing a methylenedioxy group at C-6 and C-7.  Evolantine (61), an isomer of evoxine 
(59), with a methoxy group at C-7 instead of C-5 has been isolated along with 60 in V. 
 
P a g e  | 33 
heterophylla.   Anhydroevoxine (58), evoxine (59), evolantine (61) and evoxoidine (62), all 































Scheme 14: Biosynthetic pathway to the prenylfuranoquinoline alkaloids (Grundon, 
1988) 
Pyranoquinoline alkaloids  
The pyranoquinoline alkaloids 63-74, all derivatives of flindersine (63a) are found in three 
of the Vepris species, V. bilocularis, V. louisii and V. stolzii.  They are formed by cyclisation 
of the prenyl side-chain of 4-hydroxy-2-quinolone (42a) (Scheme 15) to form an additional 
angular pyran ring on the quinoline skeleton. The various pyranoquinoline alkaloid 
derivatives arise as a result of either methylations or prenylations at the nitrogen, C-7 and C-
8.  The dimers vepridimerine A-D 71-74 were found only in V. louisii.   
 

















 R R1 R2 R3 
63 6-methoxyflindersine  H H H OCH3 
64 veprisine CH3 OCH3 OCH3 H 
65 7-methoxyflindersine H H OCH3 H 
66 7-prenyloxyflindersine H H OCH2CH=C(CH3)2 H 
67 7-prenyloxy N-
methylflindersine 
CH3 CH3 OCH2CH=C(CH3)2 H 
68 N-methyl-8-(3’,3’-
dimethylallyoxy)flindersine 
CH3 OCH2CHC(CH3)2 H H 
69 N-methyl-7-methoxy-8-(3’,3’-
dimethylallyoxy)flindersine 

















71. R = α-H



























angular pyranoquinoline  
Scheme 15: Formation of angular pyranoquinoline alkaloids (Grundon, 1988)   
1.2.4.2. Acridone alkaloids  
There are five species of Vepris that contain acridone alkaloids, ampody, bilocularis, 
fitoravina, macrophylla and pilosa (Table 6), with fitoravina and macrophylla containing 
exclusively the same suite of acridone alkaloids, 1,3-dimethoxy-N-methylacridone (79), 
arborinine (83), 1,3-dimethoxy-10-methylacridan-9-one (85) and 1-hydroxy-2,3,4-
trimethoxyacridan-9-one (86) (Koffi et al., 1987).  Together with the furanoquinoline and 
pyranquinoline alkaloids, they make the quinoline alkaloids one of the taxonomic markers 
of the genus Vepris. 
Acridone alkaloids contain a tricyclic ring having nitrogen at position 10 and a carbonyl 
group at C-9.  They are formed by the addition of three malonyl units to anthranilyl-CoA 
(N-methyl derivative of anthranilic acid) and sequential Claisen reactions, followed by 
heterocyclic ring formation by nucleophilic addition of the secondary amine on the carbonyl 
group followed by dehydration and enolisation to form the heterocyclic and the second 
aromatic ring (Scheme 16).  They differ from the quinolone alkaloids in that two extra 
malonyl units are incorporated into the skeletal backbone, resulting in a further aromatic 
ring.  Once again the acetate-derived ring is susceptible to electrophilic attack leading to 
alkylation (with DMAPP (1)) or further aromatic hydroxylation (Scheme 16).   
 



















R5 R4  
 R R1 R2 R3 R4 R5 R6 
75 melicopicine CH3 OCH3 OCH3 OCH3 OCH3 H H 
76 tecleanthine CH3 OCH3 OCH2O H OCH3 H 
77 6-methoxytecleanthine CH3 OCH3 OCH2O H OCH3 OCH3 
78 evoxanthine CH3 OCH3 OCH2O H H H 
79 1,3-dimethoxy-N-
methylacridone 
CH3 OCH3 H OCH3 H H H 
80 1,2,3- trimethoxy-N-
methylacridone 
CH3 CH3 OCH3 OCH3 H H H 
82 1-hydroxy-3-methoxy-
10-methylacridone 
CH3 OH H H H H H 




H OH OCH3 OCH3 H H H 
85 1,3-dimethoxy-10-
methylacridan-9-one 






H OH OCH3 OCH3 H H H 
87 2,4-dimethoxy-10-
methylacridan-9-one 
CH3 H OCH3 OCH3 H H H 
 
The acridone alkaloids in Vepris are mainly hydroxylated and methoxylated at various 
positions on both the aromatic rings except for C-7 and C-8.  Only two of the alkaloids, 
tecleanthine (76) and its 6-methoxy derivative (77) were functionalised on the anthranilyl 
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derived ring.  The methylenedioxy group between C-2 and C-3 is also a common occurrence 


































Scheme 16: Formation of acridone alkaloids   
1.2.4.3. Limonoids 
Three limonoids of the limonin type skeleton, including limonin (88) itself have been 
isolated in three separate Vepris species.  Limonin (88) was isolated from V. louisii and V. 
pilosa, veprisone (89) from V. bilocularis and methyl uguenenoate (90) from V. uguenensis.  
This could be the third chemotaxonomic marker for the genus Vepris, the quinolone and 
acridone alkaloids being the first two.  Thus, Vepris species such as bilocularis and lousii 
contain all three classes of compounds.  Phytochemists therefore need to keep a careful eye 
on all three classes of compounds when studying the phytochemical constituents of Vepris. 
 
























































The three Vepris limonoids possess the limonin skeleton, which from the 7α-hydroxyapo-
euphol precursor have modified rings A and D as well as side chain modification to a furan 
ring. The triterpene precursor, butyrospermol (91) (Scheme 17) is derived directly from the 
dammarenyl cation (11) (from Scheme 4) by the loss of a proton from C-7, catalysing a 
series of methyl and hydrogen migrations.  Since all three compounds isolated previously 
have a ketone at C-7, the key step in their biosynthesis is the epoxidation of the ∆7 double 
bond followed by ring opening with subsequent loss of the H-15 proton and concurrent 
Wagner-Meerwein shift of the methyl group to C-8, retaining the methyl group in the β-
position.  Subsequent oxidation to the ketone at C-7 and to the epoxide at ∆14 results in the 
two functional groups present in 88-90. 
 





























Scheme 17:  Formation of 7α-hydroxy-euphol/tirucallol via apo rearrangement 
 
The furan ring is biosynthesized through stepwise oxidation of the protolimonoid’s side-
chain to produce a hydroxyl group at C-23, a 24,25-epoxy group, and an aldehyde at C-21, 
followed by nucleophilic cyclisations from the oxygen at C-23 to the carbonyl group at C-21 
to form the hemiacetal ring.  Opening of the C-24,25 epoxide ring followed by oxidation 
produces a ketone at C-24, which then undergoes Baeyer-Villiger oxidative cleavage of the 
C-23,24 bond to give a dihydrofuran ring, which finally forms the furan ring, with the loss 
of four carbon atoms (Scheme 18).  
 



















































Scheme 18: Furan ring formation via side-chain oxidation (Bevan et al., 1967) 
In the expansion of the D ring, the key step is the allylic oxidation at C-16 of the D ring 
containing the ∆14-double bond to form an α, β unsaturated ketone.  This is followed by 
Baeyer-Villiger ring expansion to the lactone, which can occur either before or after the 
epoxidation of the ∆14 double bond (Taylor, 1984) (Scheme 19). 
 



















Scheme 19: Ring D lactone formation (Taylor, 1984).   
Ring A is contracted to a five membered ring followed by lactonization which involves the 
methyl group (CH3-19) and the carbonyl group at C-3 leading to the formation of A and A’ 
rings (A-seco) in a sequence of events starting from the deacetylation of nomilin (Scheme 
20).  Methyl uguenenoate (90) is a derivative of limonin (88) in which the A’ lactone ring 
has undergone cleavage resulting in the hydroxyl-acid, which is followed by methylation. 
 



































































Scheme 20: Biosynthesis of limonin (Adesogan and Taylor 1969) 
1.2.4.5. Cinnamic acid derivatives and simple aromatics 
Three cinnamic acid derivatives (93-95) and six simple aromatic compounds (96-102) were 
isolated from two species, V. lanceolata and V. reflexa.  Cinnamic acids are plant derived 
fragrances and flavourings having a common cinnamoyl functionality, which is present in a 
variety of secondary metabolites of phenyl propanoid biosynthetic origin (De et al., 2011).  
Chemically, cinnamic acids are aromatic fatty acids composed of an aromatic ring 
substituted with an acrylic acid group commonly in the more favoured trans geometry.  The 
acrylic acid group is a αβ-unsaturated carbonyl group which can be considered as a Michael 
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acceptor; an active moiety which is often used in the design of anticancer drugs (Ahn et al., 
1996).  The main precursor in their biosynthesis is L-Phenylalanine which undergoes 
deamination to form trans-cinnamic acid.  Further hydroxylation and methylation reactions 
result in the large variety of known cinnamic acids from plant sources.  The cinnamic acids 







  R R1 R2 
93 trans-sinapic acid methyl ester CH3 CH3 CH3 
94 alkyl trans-4-hydroxycinnamate OCH2(CH2)nCH3 H H 
95 alkyl trans-4-hydroxy-3-methoxycinnamate OCH2(CH2)nCH3 H OCH3 
 
Apart from the cinnamic acids, several simple aromatic compounds, including 
syringaldehyde (96) and syringic acid (97), the precursors to lignins as well as the aromatic 
acid, para-hydroxybenzoic acid (99), a preservative,  an ester, methyl 2,4-dihydroxy-3,6-
dimethylbenzoate (100) and ketone, 3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-
propanone (101) as well as the quinone, 2,6-dimethoxy-1,4-benzoquinone (98) were 
isolated.  The isolation of syringaldehyde (96) from V. reflexa and syringic acid (97) from V. 
lanceolata is consistent with the isolation of meso-syringaresinol (102) from V. lanceolata, 
since both the syringaldehyde and syringic acid are precursors to the lignins. 
 




























96. R = H










Surprisingly, only V. heterophylla was reported to contain flavonoids, which were all 
glycosides with the sugar moiety on the A ring, 103-108 (Gomes et al., 1983).  Flavonoids 
are derived from three malonyl CoA units which condense with each other and the 
cinnamoyl CoA unit derived from cinnamic acid which is reduced and ring closed forming 









  R R1 R2 R3 
103 vitexin H H H C-Glu 
104 7-O-acylscoparin H H CH3CO C-Glu 
105 Chrysoeriol 7-glucoside CH3O H O-Glu H 
106 2’’-O-glucosylvitexin H H H C-Glu(1→2)] 
107 2’’-O-glucosylisovitexin H C-[Glu(1→2)] H H 
108 Chrysoeriol 7-rhamnoside CH3 H C-Rha(1→2)Gal] H 
 








































Scheme 21: Condensation of three molecules of malonyl CoA with activated cinnamic 
acid (Hahlbrock and Grisebach, 1975).   
1.2.4.7. Miscellaneous compounds 
Apart from the classes mentioned above, N,N-dimethyltryptamine (109) and 
phenylacetamide (110)) have been isolated in V. ampody and an azole, unguenenazole 
(111), and amide, unguenenamide (112) were isolated from V. uguenensis. The 
indoloquinazoline alkaloids 1-hydroxyrutaecarpine (113) and 7,8-dehydro-1-
hydroxyrutaecarpine (114) were found in V. lousii.  The terpenoids, glechomanolide (115), 
1β,10β:4α,5α-diepoxy-7(11)-enegermacr-8α,12-olide (116) and 28-acetyloxy-

















































1.3 Aim of the study 
The main aim of the study was to investigate the species of Vernonia and Vepris 
phytochemically in order to determine what secondary metabolites were contained in the 
various extracts of the plant in order to validate the use of the plants in traditional medicine 
in Kenya and to provide suggestions for further use of the plant ethnomedicinally by testing 
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1.3.1 Objectives 
The research objectives were; 
1. To extract and isolate the phytochemicals from Vernonia auriculifera, Vernonia  
 urticifolia, Vepris glomerata and Vepris uguenensis leaves, stems and roots.  
2. To identify and characterise the isolated compounds using spectroscopic  
 techniques (NMR, IR, UV, CD, and MS).  
3. Based on the isolates contained in each plant, identify suitable bioassays to test  
 the compounds and thereby provide information on the further use of the plant or 
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ABSTRACT  
Phytochemical investigation of Vernonia auriculifera afforded farnesylamine, a 
sesquiterpene amine that has not been found previously in plant species, together with 
lupenyl acetate, oleanolic acid, β-amyrin acetate, β-amyrin, friedelanone, friedelin acetate, 
α-amyrin and β-sitosterol.  The compounds were characterized using NMR spectroscopy 
and by comparison with literature values.  The isolated triterpenoids exhibited moderate 
antibacterial activity, α and β-amyrin had MIC values of 0.25 mg/mL against S. aureus, B. 
subtilis, E. faecium and S. saprophyticus while lupenyl acetate and oleanolic acid exhibited 
MIC values of 0.25 mg/mL against S. maltophilia. Sub-MIC exposure of β-amyrin acetate 
was effective in decreasing adhesion of S. aureus, K. pneumonia and E. faecium while 
oleanolic acid decreased adhesion of K. pneumonia and P. aeruginosa significantly at sub-
MIC concentrations.  These compounds show potential for synergistic coupling with  
antimicrobial agents to improve therapeutic efficiency in the face of rising bacterial 
resistance.  
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INTRODUCTION 
The genus Vernonia (Asteraceae family) has more than 1000 species growing all over the 
world with more than 30 species growing in Kenya (Beentje, 1994; Oketch-Rabah et al., 
1997).  Vernonia auriculifera is a small tree or woody herb that grows between 1-7.5 m high 
and is easily recognizable by its deep purple flowers.  V. auriculifera has a wide variety of 
applications in traditional medicine.  A drop of the juice squeezed from the crushed stem 
bark, inserted into the nostrils, is known to relieve headache (Kusamba, 2001).  The Kikuyu 
people of central Kenya use the leaves of this plant as a wrap for pounded material used as a 
poultice (Kokwaro, 1976).  Heated crushed leaves of Aspilia mossambicensis, are tied in the 
leaf of V. auriculifera, and then applied over the eyes to treat conjunctivitis (Muthaura et al., 
2007).  A cold water infusion of V. auriculifera is administered orally in Uganda and Kenya 
to treat fever associated with viral and bacterial infections (Muthaura et al., 2007; 
Freiburghaus et al., 1996).  In Ethiopia, the roots are used to treat toothache (Mirutse et al., 
2009) and snake poison (Mesfin et al., 2009). 
Hydroperoxides of unsaturated fatty acid methyl esters previously isolated from V. 
auriculifera were found to have lethal toxicity (Keriko et al., 1995a).  Plant growth 
stimulators have also been identified from this plant (Keriko et al., 1995b).  Other Vernonia 
species that have received extensive phytochemical and pharmacological research include: 
V. galamensis (Miserez et al., 1996), V. brachycalyx (Oketch-Rabah et al., 1997), V. 
colorata (Rabe et al., 2002), V. amagdalina (Erasto et al., 2006), V. cinerea (Chen et al., 
2006), V. mapirensis (Morales-Escobar et al., 2007), V. cumingiana (Mao et al., 2008), V. 
ferruginea (Malafronte et al., 2009) and V. scorpioides (Buskuhl et al., 2010).  Members of 
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the genus Vernonia are an excellent source of sesquiterpene lactones which include 
vernolide, vernolepin, vernodalin and hydroxyvernolide (Kupchan et al., 1969; Jisaka et al., 
1993; Koshimizu et al., 1994).  Other compounds have also been isolated from this genus 
such as triterpenoid glycosides, flavonoids, coumarins and benzofuranones (Miserez et al., 
1996; Oketch-Rabah et al., 1997; Mao et al., 2008).  
 
The current study was undertaken primarily to investigate the phytochemistry of V. 
auriculifera from which only fatty acids were previously isolated and to test the isolated 
compounds for antimicrobial activity since extracts of Vernonia species have been cited as 
antimicrobials in traditional medicine (Kokwaro, 1976). 
MATERIALS AND METHODS 
General experimental procedure 
NMR spectra were recorded using a Bruker AvanceIII 400 MHz spectrometer.  All the 
spectra were recorded at room temperature with all chemical shifts (δ) recorded against the 
internal standard, tetramethylsilane (TMS).  IR spectra were recorded on a Perkin Elmer 
Spectrum 100 FT-IR spectrometer with universal ATR sampling accessory.  For GC-MS 
analyses, the samples were analysed on an Agilent GC–MSD apparatus equipped with DB-
5SIL MS (30 m x 0.25 mm i.d., 0.25 µm film thickness) fused-silica capillary column. 
Helium (at 2 ml/min) was used as a carrier gas.  The MS was operated in the EI mode at 70 
eV. Optical rotation was recorded using a PerkinElmerTM, Model 341 Polarimeter.  
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Plant Material 
The leaves, stem bark and root bark of V. auriculifera were collected in August, 2009 from 
Egerton University Botanical Garden, Rift Valley Province in Kenya.  The plant was 
identified by taxonomist, Dr S. T. Kariuki, of the Botany Department, Egerton University, 
Kenya and a voucher specimen (Kiplimo, 02) was deposited in the Ward Herbarium, 
University of KwaZulu-Natal Westville, Durban, South Africa. 
 
Extraction and isolation 
The air-dried and ground plant material of V. auriculifera (823 g leaves, 710 g roots, 600 g 
stems) was sequentially extracted with organic solvents in order of increasing polarity viz; 
hexane, dichloromethane, ethyl acetate and methanol using a Soxhlet apparatus for 24 h in 
each case.  The yields obtained for each solvent were, hexane 66.68 g (leaves), 9.10 g 
(roots), 16.73 g (stems); dichloromethane 16.77 g (leaves), 5.13 g (roots), 9.25 g (stems); 
ethyl acetate 8.28 g (leaves), 0.93 g (roots), 5.02 g (stems) and methanol, 27.01 g (leaves), 
20.28 g (roots), 15.09 g (stems). 
 
Isolation and purification of compounds 1, 3, 4, 5, 8 and 9 
The hexane extract from the leaves (30 g) was separated by column chromatography using a 
step gradient of  hexane: dichloromethane: ethyl acetate gradient, starting with 100% hexane 
stepped to 10%, 20%, 30%, 50%, 80% and 100% dichloromethane, followed by  20% and 
30% ethyl acetate in dichloromethane.  Twenty fractions of 100 mL each were collected in 
each step.  Fractions 5-12 were combined and purified using 100% hexane, to produce 
farnesylamine (9) (12 mg).  Fractions 21-25 were recrystallised in methanol to yield 
sitosterol (8) (78 mg).  Fractions 41-67 were combined and separated with 20% and 30% 
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dichloromethane in hexane.  Lupenyl acetate (1) (52 mg) was obtained in fractions 8-12 
while fraction 18-35 was further purified using 20% ethyl acetate in hexane where fractions 
5-9 afforded β-amyrin acetate (4) (150 mg) and fractions 11-18 afforded a mixture of α-
amyrin (5) and β-amyrin (3) (89 mg).   
 
Isolation and purification of compound 2 
The ethyl acetate extract (0.93 g) from the roots was dissolved in dichloromethane and 
separated with a mobile phase consisting of a hexane: ethyl acetate step gradient 1:0 
(fractions 1-10), 9:1 (fractions 11-20), 7:3 (fractions 21-38), 6:4 (fractions 52-64) and 3:7 
(fractions 65-70).  Fractions 22-27 were further purified with 20% ethyl acetate in hexane.  
Oleanolic acid (2) (25 mg) was obtained in fractions 9-13. 
 
Isolation and purification of compounds 6 & 7 
The hexane extract from the stems (16.73 g) was subjected to column chromatography.  The 
mobile phase consisted of a hexane: dichloromethane step gradient; 1:0 (fractions 1-45), 9:1 
(fractions 46-66), 8:2 (fractions 67-80), 7:3 (fractions 81-98) and 1:1 (fractions 99-121).  
Friedelin acetate (7) (31 mg) was eluted in fraction 24-32 and the pure compound was 
obtained by recrystallisation in methanol.  Friedelanone (6) (120 mg) was obtained by 
purification of fractions 55-80 using 10% dichloromethane in hexane as the mobile phase 
where the compound was eluted in fraction 7-15, followed by recrystallisation in methanol. 
Farnesylamine (9)  
White crystals, m/z (rel %): 221 [M]+, 206 (1), 189 (3), 179 (3), 161 (3); IR spectra (Vmax 
cm-1): 3413, 2919, 1357, 1053; 1H NMR spectral data (400 MHz, CDCl3) δH 5.11(H-2, 6, 
10), 2.07 (2H-1), 2.06 (2H-4), 2.05 (2H-9), 2.03 (2H-5), 1.69 (3H-12), 1.62 (3H-13, 3H- 14, 
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3H-15), 1.28 (2H-8); 13C NMR spectral data (400 MHz) 134.82 (C-3), 134.16 (C-7), 130.97 
(C-11), 124.12 (C-6), 124.02 (C-10), 123.98 (C-2), 39.45 (C-1, 4), 29.42 (C-8), 27.99 (C-5), 
26.48 (C-9), 25.41 (C-12), 17.39 (C-13), 15.75 (C-14), 15.71 (C-15). 
BIOLOGICAL STUDIES 
Minimum inhibitory concentration (MIC)  
Four strains of Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas 
aeruginosa ATCC 35032, Klebsiella pneumonia ATCC 700603 and Stenotrophomonas 
maltophilia ATCC 13637) and five Gram-positive bacteria (Staphylococcus aureus ATCC 
25923, Bacillus subtilis ATCC 6051, Enterococcus faecium ATCC 19434, Staphylococcus 
epidermidis ATCC 14990 and Staphylococcus saprophyticus ATCC 35552) were selected 
for the determination of  antimicrobial activity. 
 
The antibacterial activities of the compounds were determined using the broth microdilution 
method as described by Andrews (2001).  Bacterial strains were cultured for 18 h at 37 oC in 
Tryptone Soy Broth (TSB) and standardized to a final cell density of 1.5×108 cfu/mL 
equivalent to 0.5 McFarland Standard.  The 96-well plates were prepared by dispensing into 
each well, 90 µL Muller-Hinton (MH) broth and 10 µL of the bacterial inoculum.  Test 
compounds were dissolved in dimethyl sulfoxide (DMSO) to a concentration of 10 mg/mL 
while tetracycline (a broad-spectrum antimicrobial agent) the positive control was dissolved 
in ethanol.  Serial two-fold dilutions were made in a concentration range of 0.002 to 2 
mg/mL.  Wells containing MH broth only were used as a medium control and wells 
containing medium and cultures without the test compound were used as the growth control.  
Plates were covered to avoid contamination and evaporation and incubated for 24 h at 37 oC.  
The minimum inhibitory concentration (MIC) was described as the lowest concentration of 
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the test compounds that completely inhibited the growth of microorganisms.  The tests were 
done in triplicate on two separate occasions and the results are as shown in table 2. 
 
Anti-biofilm activity evaluation 
To determine the anti-biofilm activity of β-amyrin acetate and oleanolic acid, three strains of 
Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 
35032 and Klebsiella pneumonia ATCC 700603) and four Gram-positive bacteria 
(Staphylococcus aureus ATCC 25923, Staphylococcus aureus ATCC 43300, Enterococcus 
faecium ATCC 19434, and Staphylococcus saprophyticus ATCC 35552) were used.  
Bacterial isolates were cultured overnight in TSB to determine the effect of MIC, sub-MIC 
(0.5×MIC) and supra-MIC (2×MIC) exposures on biofilm formation.  Cells were washed 
and resuspended in distilled water to a turbidity equivalent to a 0.5 McFarland standard.  
Wells of sterile, 96-well U-bottomed microtiter plates were each filled with 90 µL Luria 
Bertani broth (LB) and 10 µL of cell suspension, in triplicate.  Based on individual MICs for 
each isolate the effect of MIC, sub-MIC and supra-MIC of β-amyrin acetate and oleanolic 
acid on bacterial adhesion was investigated.  Plates were incubated aerobically at 37 ˚C for 
24 h with shaking on an Orbit P4 microtitre plate shaker (Labnet). 
 
The contents of each well were aspirated and then washed three times with 250 µL of sterile 
distilled water.  To remove all the non-adherent bacteria, the plates were vigorously shaken 
and the remaining attached cells were fixed with 200 µL of 99% methanol per well.  After 
15 min, plates were left to dry and then stained for 5 min with 150 µL of 2% Hucker crystal 
violet.  Excess stain was washed with running tap water and plates were left to air dry 
(Basson et al., 2008).  The bound stain was resolubilised with 150 µL of 33% (v/v) glacial 
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acetic acid per well.  The Optical Density (OD) of the contents of each well was obtained at 
595 nm using the Fluoroskan Ascent F1 (Thermolabsystems). 
 
Tests were done in triplicate on two separate occasions and the results were averaged 
(Stepanović et al., 2000).  The negative control for both assays was un-inoculated LB, while 
the positive control was tetracycline, with respective cell suspensions without β-amyrin 
acetate or oleanolic acid. OD595nm values of treated cells were compared with untreated cells 
to investigate the increase/decrease of biofilm formation as a result of antimicrobial agent 
exposure.  Treated and untreated samples were compared statistically using paired t-tests 
and Wilcoxon signed rank tests if normality failed using a SigmaStat V3.5, Systat Software. 
RESULTS AND DISCUSSION 
The phytochemical investigation of V. auriculifera led to the isolation of eight triterpenoids 
1-8 and a sesquiterpene amine (9) (Figure 1).  Extracts from the leaves were found to 
contain the sesquiterpene amine along with one lupane-type triterpenoid (lupenyl acetate 1), 
one ursane-type triterpenoid (α-amyrin 5), two oleanane-type triterpenoids (β-amyrin 3 and 
β-amyrin acetate 4) and a common steroid (sitosterol 8) (Figure 1).  The stem bark afforded 
friedelanone (6) and friedelin acetate (7) belonging to the friedelane class.  From the roots, 
oleanolic acid (2), the parent oleanane type triterpene, was isolated.  Compounds 1-8 were 
identified using 2D NMR spectral data and by comparison with literature values, which 
supported the structures as lupenyl acetate (Jamal et al., 2008), oleanolic acid (Seebacher et 
al., 2003), β-amyrin, β-amyrin acetate, friedelin acetate and α-amyrin (Mahato and Kundu, 
1994), friedelanone (Igoli and Gray, 2008) and sitosterol (Kamboj and Saluja, 2011).  
Although farnesylamine (9) was previously reported (Jones et al., 2003), here we are 
reporting the complete data for the first time. 
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Compound 9 was isolated as a colourless oily liquid; its molecular formula was assigned as 
C15H27N.  The IR spectrum showed the presence of a primary amine (3413 cm
-1) and (1375 
cm-1). The 13C NMR spectrum showed the presence of six olefinic carbon resonances, 3-
protonated carbon resonances at δC 124.12 (C-6), 124.02 (C-10) and 123.98 (C-2) and 3-
non-protonated carbons at δC 130-135.  The olefinic methine resonances could also be seen 
at δH 5.11 in the 
1H NMR spectrum.  The methylene carbon resonances were observed 
between δC 26.48 and δC 29.42 except for the methylene bonded to the amine group which 
was observed downfield at δC 39.47.  All the methylene proton resonances, including 2H-1 
were present at δH 2.05 except for one methylene resonance which appeared upfield at δH 
1.27.  Three of the four methyl proton resonances overlap at δH 1.62 (3H-13, 14, 15) and one 
is in a different chemical environment at δH 1.69 (3H-12).  The methyl carbon resonances 
can be seen in the 13C NMR spectrum between δC 25.41 and δC 15.71.  This compound has 
been detected in an extract of the ant Monomorium fieldi Forel from Australia (Jones et al., 
2003) and has only now been found in a plant species. 
 
 




1 lupenyl acetate 2 R1 = OH; R2 = COOH (oleanolic acid)
3 R1 = OH; R2 = CH3 (β−amyrin)
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Figure 1: Structures of compounds (1-9) isolated from Vernonia auriculifera. 
The triterpene family of compounds to which all the isolated compounds belong are 
reported to possess antibacterial activity (Collins and Charles, 1987).  The sesquiterpene, 
farnesylamine, could not be screened for antibacterial activity due to sample decomposition.  
MIC values recorded for all tested compounds (Table 2) suggested moderate antibacterial 
activity.  The most active compounds were amyrins (mixture of α-and β-), with MICs of 
0.12 mg/mL against E. coli, 0.25 mg/mL against S. aureus, B. subtillis, E. feacalis, S. 
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saprophyticus, and 0.5mg/mL against S. epidermis, K. pneumonia, and S. maltophilia.  The 
other compounds 3-7 had a MIC of 0.5 mg/mL against S. maltophilia.  The least active 
compounds were 6 and 7 with a MIC of 1.0 mg/mL against six microorganisms.  All tested 
compounds had MICs of 1.0 mg/mL for P. aeruginosae and 0.5 mg/mL for S. maltophilia.  
The oleanane triterpernoids (2-4) displayed better antibacterial activity than the friedelane 
triterpenoids (6-7).  It is reported that the 28-COOH and ester functionality at C-3 
contributes to pharmacological activities of pentacyclic triterpenes (Mallavadhi et al., 2004) 
like lupenyl which has greater antimutagenic activity than lupenyl acetate (Guevara et al., 
1996).  These effects are observed for friedelanone and friedelin acetate where the ketone 
has higher activity against Bacillus subtilis than the ester.  
 
Table 1: Minimum inhibitory concentrations (MIC in mg mL
-1
) of compounds isolated 
from V. auriculifera 
  MIC (mg mL
-1
) of the test organisms 
Microoganism 1 2 3 & 5 4 6 7 
S. aureus 1.0 0.5 0.25 1.0 1.0 1.0 
B. subtilis 1.0 0.5 0.25 1.0 0.25 1.0 
E. faecium 0.5 1.0 0.25 0.5 1.0 1.0 
S. epidermidis 1.0 0.25 0.5 1.0 0.5 0.5 
S. saprophyticus 0.25 1.0 0.25 1.0 1.0 1.0 
E. coli 0.12 1.0 0.12 0.5 1.0 0.5 
K. pneumonia 1.0 0.5 0.5 1.0 1.0 1.0 
P. aeruginosa 1.0 1.0 1.0 1.0 1.0 1.0 
St. maltophilia 0.25 0.25 0.5 0.5 0.5 0.5 
Key: 1= lupenyl acetate, 2 = oleanolic acid, 3 = β-amyrin, 4 = β-amyrin acetate, 
                5 = α−amyrin, 6 = friedlanone, 7 = friedlin acetate 
 
Biofilm is a microbially derived sessile community characterized by cells that are 
irreversibly attached to a substratum or interface or to each other and are embedded in a 
matrix of extracellular polymeric substances they have produced.  When planktonic bacteria 
adhere to surfaces, they initiate biofilm formation.  The nature of biofilm structure and 
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physiological attributes of biofilm organisms confer an inherent resistance to antimicrobial 
agents such as antibiotics, disinfectants or germicides (Donlan et al., 2002).  
β-amyrin acetate and oleanolic acid were tested for antibiofilm activity against seven strains 
of bacteria.  β-amyrin acetate decreased adhesion of S. aureus (ATCC 43300), K. 
pneumonia and E. faecium significantly at sub-MIC concentrations (figure 2).  For K. 
pneumonia, this decreased adhesion was also seen at MIC concentrations and in S. 
saphrophyticus a marked decrease in adhesion was seen at MIC and supra MIC 
concentrations.  Sub-MIC oleanolic acid exposure also decreased adhesion of K. pneumonia 
and P. aeruginosa significantly (figure 3), but MIC and supra-MIC exposures of oleanolic 
acid increased adhesion of all tested bacterial strains.  These results suggest that oleanolic 
acid and β-amyrin acetate that are relatively abundant, can be used at low concentrations to 
decrease adhesion of certain bacterial strains to abiotic surfaces.  Since bacterial resistance 
to antibiotics and their survival are associated with their ability to form biofilms (Donlan et 
al., 2002), compounds which decrease biofilm formation would be useful in being used in 
conjunction with other antibiotics to decrease bacterial resistance.  Agents that decrease 
adhesion of bacteria may also be useful in improving the efficacy of antibiotics and hygiene 
in hospitals that have devices such as incubation tubes, catheters, artificial heart valves, 
water lines and cleaning instruments on which bacterial biofilm have been found (Donlan et 
al., 2002). 
 




























































































































































































































































































































Figure 3: Antibiofilm results for oleanolic acid (2) 
CONCLUSION 
This is the first report of a phytochemical investigation of V. auriculifera.  The finding of a 
sesquiterpene amine in V. auriculifera is unique as it has not been isolated from a plant 
species before.  Although the genus Vernonia is known to be a rich source of sesquiterpene 
lactones, none were isolated from V. auriculifera.  However, eight pentacyclic compounds 
with moderate antibacterial activity were isolated.  Oleanolic acid and β-amyrin acetate 
exhibited moderate anti-adhesion properties.  These compounds show potential for 
synergistic coupling with antimicrobial agents to improve therapeutic efficiency, in the face 
of rising bacterial resistance, however this needs further investigation.  
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ABSTRACT 
A new polyene metabolite, urticifolene together with a known carotenoid, lutein and 
sitosterol were isolated from the leaves of Vernonia urticifolia and fully characterized.  
Lutein (2) inhibited the growth of Enterococcus faecium at a low concentration (MIC of 8 
µg/mL), while urticifolene (1) inhibited the growth of Enterococcus faecium and 
Pseudomonas aeruginosa at low concentrations (MIC of 16 and 32 µg/mL respectively).  In 
contrast to the related polyenes, nystatin and amphotericin B, which exhibit no activity 
against bacteria, urticifolene exhibited inhibitory property against all the bacteria 
investigated. 
Keywords: Urticifolene, lutein, Vernonia urticifolia, Asteraceae, antibacterial.  
INTRODUCTION 
Ethnomedicinally, Vernonia species are employed in the treatment of a diverse range of 
ailments, including measles, skin rashes, backache, malaria (Anoka et al., 2008), asthma, 
bronchitis, dysentery and worms (guinea, round and thread) (Misra et al., 1984).  The root of 
V. cinerea is used as an anthelmintic and diuretic (Misra et al., 1984) and to treat, coughs 
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intestinal colics and chronic skin diseases (Dastur, 1977).  V. calvoana, a leafy vegetable is 
found to be a rich source of provitamin A, particularly cis-β-carotene (Ejoh et al., 2010). 
Several Vernonia species have previously been investigated, of which V. amagdalina is 
extensively investigated for its pharmacological properties (Kupchan et al., 1963, Ohigashi 
et al., 1994).  V. brasiliana and V. brachycalyx have shown potential antiprotozoal activity 
(Almeida Alves de et al., 1997; Oketch-Rabah et al., 1997).  V. urticifolia, the subject of the 
present study is known as Motoiyokwo by the Kalenjin tribe of Kenya, who use it to treat 
sinuses, allergy and skin rashes (Kokwaro, 1976).  
There are no previous phytochemical or pharmacological studies carried out on this plant.  
The current study was undertaken to investigate the phytochemistry of V. urticifolia and to 
test the isolated compounds for antibacterial activity since extracts of Vernonia species have 
been reported to possess antimicrobial activities and are used in traditional medicine 
(Kokwaro, 1976).  We present herein a detailed isolation, characterization and antibacterial 
activity of the isolated compounds. 
MATERIALS AND METHODS 
Plant material  
The leaves of Vernonia urticifolia (762.87 g) were collected from Nakuru District, Kenya in 
June 2010.  The plant was identified by Mr Ezekiel Cheboi of the Department of Natural 
Resources, Egerton University, Kenya. A voucher specimen (Kiplimo 03) was retained at 
the Ward Herbarium University of KwaZulu-Natal Westville, Durban. 
Extraction and Isolation of Compounds  
The air-dried and ground leaves were extracted sequentially using a soxhlet apparatus with 
solvents of increasing polarity viz: hexane, dichloromethane, ethyl acetate and methanol.  
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The dichloromethane extract was concentrated to yield a crude extract (6.94 g) which was 
separated using column chromatography over silica gel (Merck 9385) and eluted with a 
hexane/ethyl acetate step gradient, to yield three subfractions D1-D3. Compound 1 (32 mg) 
was obtained in fraction D2 and compound 2 (43 mg) was obtained in fraction D3. 
GENERAL EXPERIMENTAL PROCEDURE 
Melting points were determined on an Ernst Leitz Wetziar micro-hot stage melting point 
apparatus.  NMR spectra were recorded at room temperature on a 400MHz varian UNITY–
INOVA spectrometer.  1H NMR spectra were referenced against the CHCl3 signal at δH 7.24 
and 13C NMR spectra against the corresponding signal at δC 77.0. Coupling constants are 
given in Hz. For GC-MS analyses, samples were analysed on an Agilent GC–MSD 
apparatus equipped with a DB-5SIL MS (30 m x 0.25 mm i.d., 0.25 µm film thickness) 
fused-silica capillary column.  The MS was operated in the EI mode at 70 eV, in m/z range 
42–350.  IR spectra were recorded on a Nicolet impact 400D Fourier Transform Infrared 
(FT-IR) spectrometer, using NaCl windows with CHCl3 as solvent against an air 




Three strains of Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas 
aeruginosa ATCC 35032, Klebsiella pneumonia ATCC 700603), and three Gram-positive 
bacteria (Staphylococcus aureus ATCC 25923, Enterococcus faecium ATCC 19434, 
Staphylococcus saprophyticus ATCC 35552) were selected to determine the antibacterial 
activity of the isolated compounds.  
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Determination of minimum inhibitory concentration (MIC) 
The antibacterial activities of the compounds were determined using the broth microdilution 
method as described by Andrews, 2001; Bacterial strains were cultured for 18 h at 37 oC in 
Tryptone Soy Broth (TSB) and standardized to a final cell density of 1.5×108 cfu/ml 
equivalent to 0.5 McFarland standard.  The 96-well plates were prepared by dispensing into 
each well, 90 µl Muller-Hinton (MH) broth and 10 µl of the bacterial inoculum.  Test 
compounds were dissolved in dimethyl sulfoxide (DMSO) to a concentration of 10 mg/ml 
while tetracycline (a positive control) was dissolved in ethanol.  Serial two-fold dilutions 
were made in a concentration range of 0.002 to 1 mg/ml.  Wells containing MH broth only 
were used as medium control and wells containing medium and cultures without the test 
compound were used as the growth control. Plates were covered to avoid contamination and 
evaporation and incubated for 24 h at 37 oC.  The minimum inhibitory concentration (MIC) 
was described as the lowest concentration of the test compounds completely inhibiting the 
growth of microorganisms.  The tests were done in triplicate on two separate occasions 
(Table 2). 
RESULTS AND DISCUSSION 
The dichloromethane extract of the powdered leaves of V. urticifolia afforded a new 
polyene, (urticifolene, 1), known carotenoid (lutein, 2) and the known triterpenoid, 
(sitosterol) that is ubiquitous in the Vernonia family.  This is the first report of compound 1; 
a yellow oily solid which has been assigned the trivial name urticifolene.  The molecular 
formula was established to be C31H52O4, as indicated by the M
+ ion at m/z 488 in the mass 
spectrum, which implied six degrees of unsaturation.  The IR spectrum revealed the 
presence of hydroxyl (3396 cm-1) and carbonyl (1713 cm-1) functional groups.  The UV 
spectrum of urticifolene, 1 showed maxima with three shoulders at 237, 245 and 322 nm 
 
P a g e  | 89 
consistent with the conjugated double bonds present in the compound.  The 13C NMR 
spectrum of urticifolene, 1 (Table 1) showed ten carbon resonances in the olefinic region 
(range 123-135 ppm) indicating five double bonds, a carbonyl carbon resonance at δC 
179.23 (accounting for the six degrees of unsaturation) and two oxygenated methine carbon 
resonances at δC 72.95  and 72.18. 
1H NMR data displayed one methyl group bound to an 
aliphatic carbon at δH 0.89 and overlapping olefinic resonances which appeared between δH 
5.0 and 7.0, characteristic of polyenes.  Also present in the 1H NMR spectrum were two 
overlapping signals at δH 4.17 and δH 4.22, their deshielded chemical shifts confirming the 
presence of two hydroxyl groups at C-3 and C-29.   
The COSY spectrum revealed a correlation between H-3 and H-2 in the olefinic region and 
H-2 showed correlations with C-3 (δC 72.95) in the HMBC spectrum.  The geometry of the 
double bonds at ∆5 and ∆8 were determined to be trans based on the coupling constants of 
J5,6 = 15.0 Hz and J8,9 = 15.5 Hz.  The geometry of the other three double bonds could not be 
determined as all the resonances overlapped and the coupling constants could not be clearly 
determined.  These were however given the more stable trans configuration.  Only the 
olefinic proton resonances of H-5, H-6, H-8 and H-9, the deshielded methine resonances of 
H-3 and H-29, the methylene resonances at C-2 and C-30 (which overlap) and the methyl 
resonance at δH 0.89 can be distinguished along with their corresponding carbon resonances 
by using the HSQC spectrum.   All the other methylene proton resonances as well as the 
olefinic resonances of H-11-H-14 as well as that of H-26 and H-27 all overlapped in their 
respective regions of the NMR spectrum and could not be distinguished from each other.  
The double bonds at ∆5 and ∆8 were separated by a methylene resonance as these two 
double bonds were not conjugated as evidenced by separate resonances that coalesced for 
both H-5 and H-6 and for H-8 and H-9.  The olefinic resonances of H-11 to H-14 all 
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overlapped in the olefinic region of the spectrum into more complex splitting patterns, 
which will only result if the two double bonds at ∆11 and ∆13 are conjugated.  With regard to 
the double bond at ∆26, one of the olefinic resonances in overlapping region at δ 5.75 shows 
a HMBC correlation to the methine proton resonance of H-29.  This indicates that the 
double bond is in close proximity to the oxygenated methine group and was therefore placed 
at ∆26 as a HMBC correlation to the carbony resonance was absent for it to be placed at ∆27. 
There is however a lack of correlations in the spectra to assign a structure to this compound 
unequivocally, however the proposed structure best fits the data. 
 Urticifolene (1) displayed high structural similarity to laetiporic acid isolated from 
Laetiporus sulphureus with the exception of the aliphatic methylene chain containing 13 
carbon atoms in urticifolene (1) that is absent in laetiporic acid (Davoli et al., 2005).  
Compound 2 was identified as Lutein due to characteristic peaks observed in the 
spectroscopic data.  The UV spectrum showed absorption maxima at 454 nm, 480 nm and 
430 nm.  This was consistent with the UV data of (9Z, 9’Z, 3R, 3’R, 6’R)-lutein isolated 



































































Figure 1. Structures of compounds (1 & 2) isolated from Vernonia urticifolia 
 
 





C NMR spectral data of compound 1 and 2 (400 or 100 MHz) 
 urticifolene (1) lutein (2) 
position δC δH position δC δH
 
1 14.19 0.89 1 37.13 - 




20.74-33.93  1.20-2.30  3 65.10 4.03 
3 72.95  4.17 4 42.56 2.05, 2.42 
5 125.82  6.52  5 126.17 - 
6 125.91  6.48  6 138.00 - 
8 127.84 6.02  7 128.73 6.12 
9 127.78 5.98 8 130.81 6.65 
11-14, 
26-27 
132.80-135.70  5.25-5.75 9 135.07 - 
29 72.18 4.22 10 130.04 6.07 
30 37.25 2.34 11 124.49 6.73 
31 179.23   12 137.57 6.28 
   13 136.42 - 
   14 132.58 6.23 
   15 130.09 6.63 
   16 30.26 1.08 
   17 28.73 1.09 
   18 21.62 1.78 
   19 29.70 1.97 
   20 12.81 1.97 
   1’ 34.04 - 
   2’ 44.64 1.37, 1.85 
   3’ 65.93 4.25 
   4’ 128.81 5.50 
   5’ 137.77 - 
   6’ 54.97 2.47 
   7’ 131.30 5.47 
   8’ 130.09 6.65 
   9’ 135.70 - 
   10’ 125.60 6.05 
   11’ 124.94 6.74 
   12’ 138.50 6.28 
   13’ 136.49 - 
   14’ 137.73 6.23 
   15’ 130.81 6.63 
   16’ 29.50 0.85 
   17’ 24.29 1.03 
   18’ 22.86 1.64 
   19’ 12.76 1.90 
   20’ 13.11 1.95 
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The antibacterial activity results (Table 2) shows that urticifolene, 1 and lutein, 2 had broad 
spectrum antibacterial activity.  The minimum inhibitory concentration (MIC) determination 
showed that lutein at low concentration of 8 µg/mL completely inhibited the growth of 
Enterococcus faecium (ATCC 19434) and at 32 µg/mL it inhibited the growth of 
Staphylococcus aureus (ATCC 29212 ), Escherichia coli (ATCC  25922 ) and Klebsiella 
pneumonia (ATCC 700603).  Urticifolene inhibited the growth of Pseudomonas aeruginosa 
(ATCC 35032) and Enterococcus faecium (ATCC 19434) at low concentrations of 32 
µg/mL and 16 µg/mL respectively, but the MIC for Escherichia coli (ATCC 25922), 
Klebsiella pneumonia (ATCC 700603) and Staphylococcus aureus (ATCC 29212,) were 
recorded as 256 µg/mL.  These findings indicated that urticifolene (1) and lutein (2) 
possessed inhibitory activity against bacteria.  Other investigations showed that the 
carotenoid methanol extract of the citrus the peel of Shatian pummel exhibited inhibitory 
properties within a range of 18.75-140.00 µg/mL against E. coli, S. aureus and B. subtilis 
(Tao et al., 2010). 
 
The constituents of citrus carotenoids cover a wide range of compounds such as β-
cryptoxanthin, violaxanthin isomers, lycopene and β-carotene (Tao et al., 2010) therefore 
the synergistic effect of these compounds could have possibly enhanced the activity of the 
methanol carotenoid extract.  It has also been reported that some polyenes (of which 
urticifolene, 1 belongs) such as amphotericin B and nystatin have no antibacterial activity 
whilst others such as faeriefungin inhibit the growth of a variety of bacterial isolates.  The 
mode of action of carotenoids is not clearly understood but Cucco et al., 2007) suggest that 
β-carotene could lead to the accumulation of lysozyme (a bacterial immune enzyme that 
digests bacterial cell walls).  But the mode of action of polyenes against bacteria is 
unknown, though the fungicidal activity involves interaction of the lipophilic polyene 
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structure with the cytoplasmic membrane sterol found in fungi and mammalian cells 
resulting in alteration of the cell membrane, leakage of cell constituents and cell death 
(Mulks et al., 1990).  
Table 2 Minimum inhibitory concentration (MIC) of urticifolene and lutein 
 Concentration  (µg/ml)  
Test organism Urticifolene           lutein                                           
E. faecium, (ATCC 19434) 16           8 
S. aureus, (ATCC 29212) 256           32 
S.  saprophyticus, (ATCC 35552) 128           256 
E. coli, (ATCC 25922) 256            32 
 K. pneumonia, (ATCC 700603) 256            32 
 P. aeruginosa, (ATCC 35032) 32           256 
   
 
CONCLUSION 
The phytochemical study of this plant resulted in the isolation of two compounds, a polyene 
and a carotenoid.  These compounds exhibited moderate antibacterial activity.  In contrast to 
the related polyene antibiotics, nyastin and amphotericin B, which are inactive against 
certain bacteria, urticifolene exhibited inhibitory activity against all the bacteria 
investigated.  These results provide scientific validity and credence to the ethnomedicinal 
use of this plant in the treatment of ailments caused by some of the bacteria used in this 
study and highlights the usefulness of V. urticifolia in the treatment of bacterial infections. 
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Abstract 
The dichloromethane extract of the aerial part of the plant Vepris glomerata (Rutaceae) 
yielded a new flavonoid, which was accorded the trivial name veprisinol (1), together with 
four known furoquinoline alkaloids: isohaplopine-3,3’-dimethylallyl ether (2), tecleoxine 
(3), nkolbisine (4) and skimmianine (5).  The structures of the compounds were established 
by 1D and 2D NMR spectroscopy, as well as HREIMS.  Compounds 1 and 2 have strong 
antioxidant potential, similar to and in some instances better than ascorbic acid and can be 
used as beneficial additives to antioxidant supplements.  
Keywords: Vepris glomerata, veprisinol, furoquinoline alkaloids, antioxidant activity. 
Introduction 
The African Vepris species have proved to be a good source of furoquinoline and acridone 
alkaloids that typify the genus as a whole. V. bilocularis has been found to have both 
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furoquinoline as well as acridone alkaloids [1, 2], while furoquinoline alkaloids alone have 
been found in V. ampody [3], V. heterophylla [4], V. punctata [5] and V. stolzii [6], and 
acridone alkaloids alone in V. fitoravina and V. macrophylla [7].  The alkaloids are reported 
to possess broad spectrum antimicrobial [8], antiradical [9], antioxidant [10], antiplasmodial 
[11], anticancer [12] and antimutagenic [13] activities.  V. glomerata is used in African 
traditional medicine, where its aqueous root extract is used to treat malaria, epilepsy, 
psychosis and stroke, when mixed with tea [14].  Earlier pharmacological studies on this 
plant reported antiplasmodial activities of the ethanol extract [15].  
Since the species of Rutaceae are often cited as antimalarials or febrifuges in African 
traditional medicine [14] and the antioxidant activity of alkaloids [10] and flavonoids [16] 
has previously been demonstrated, all the five compounds isolated were assessed for 
antioxidant activity using three methods.   
Here we report on the isolation and structure elucidation of a new flavonoid, in addition to 
four known furoquinoline alkaloids: isohaplopine-3,3’-dimethylallyl ether (2), tecleoxine 
(3), nkolbisine (4) and skimmianine (5) from the  dichloromethane extract of V. glomerata, 
together with their antioxidant activities in vitro.  The structures of the known compounds 2-
5 were determined by comparison of their physical and spectroscopic data with those 
reported in literature; 2 and 3 [17], 4 [18] and 5 [19].  Only skimmianine and evoxine 
(montrifoline) were previously reported from the leaves of V. glomerata endemic to 
Ethiopia [20].  It is not apparent if the additional compounds found in this study are as a 
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Compound 1 was obtained as a yellow solid.  Its mass was established to be 388.1573 amu, 
based on HREIMS data, corresponding to a molecular formula of C21H24O7, which indicates 
a double bond equivalence of 10, eight being due to the aromatic rings, one being due to the 
carbonyl group and one to ring C of the flavanone skeleton.  The IR spectrum showed a 
carbonyl stretching band at 1705 cm-1 and a hydroxyl absorption band at 3364 cm-1.  This 
compound was identified as a flavanone based on its characteristic 1H NMR spectral pattern.  
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The characteristic ABX coupling system of H-2β, H-3α and H-3β appeared at δH 5.29 (1H, 
dd, J = 12.84, 2.84 Hz, H-2β), δH 3.04 (1H, dd, J = 17.12, 2.84 Hz, H-3α) and δH 2.75 (1H, 
dd, J = 17.12, 12.84, Hz, H-3β).  These signals also showed COSY and NOESY correlations 
with each other. 
Another characteristic pattern was that of the trisubstituted aromatic B ring.  The proton 
resonances of this ring occurred as a singlet at δH 7.00 (s, H-2’) and doublets at δH 6.89 and 
6.84 (1H each, d, J = 8.48 Hz, H-5’ and H-6’).  The small coupling constant of about 2 Hz 
for JH2’,H6’ could not be detected for the H-2’ resonance.  The 
1H NMR spectrum also 
showed the presence of a methoxy group at δH 3.88 (s), its position at C-4’ being confirmed 
by both a 1D NOE and a NOESY correlation with the resonances at δH 6.89 and 6.84 (H-5’ 
and H-6’).  Five aromatic C-O resonances were seen at δC  164.0, 167.2, 162.8, 145.0 and 
147.0 attributed to oxygenation at C-5, 7, 9, 3’ and 4’. 
A pair of doublets at δH 6.02 (1H, d, J = 1.76 Hz, H-6) and δH 6.00 (1H, d, J = 1.76 Hz, H-8) 
were attributed to the meta coupled, H-6 and H-8 protons on ring A.  These two proton 
resonances showed NOESY correlations to 2H-1’’ at δH 4.02, confirming the position of the 
side chain at C-7.  Its corresponding carbon resonance showed HMBC correlations to two 
multiplets  at  δH 1.87 (overlapping resonances of H-2’’a and H-3’’) and δH 1.61 (H-2’’b).  
The H-2’’ resonances were diastereotopic and appeared as two separate resonances.  COSY 
correlations were also observed between H-1’’ and H-2’’a and H-2’’b and between H-2’’b 
and H-3’’.  The H-3’’ methine proton was coupled to the methyl proton resonance at δH 0.95 
(d, J = 6.52 Hz) attributed to 3H-5’’ and the methylene proton at δH 3.50 (2H-4’’) in the 
COSY spectrum.  These correlations formed a side chain which was attached to ring A by 
an ether linkage at C-7.  Compound 1 was thus identified as 4H-1-benzopyran-4-one-2,3-
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dihydro-5-hydroxy-2-(4’-methoxy-3’-hydroxybenzyl)-7-O-(2-methyl butanol) ether, and 
given the trivial name veprisinol. 
The results of the reducing potential (transformation of Fe3+-Fe2+) of the standard (ascorbic 
acid) and compounds 1-5 are shown in figure 1.  The activity of isohaplopine-3,3’-
dimethylallyl ether, 2 and veprisiniol (1) was significantly higher than the activity of the 
other three alkaloids at all concentrations.  However, the reducing power of compound 1 
was significantly lower than that of compound 2.  The reducing power of the compounds 
and standard followed the order: ascorbic acid > 2 > 1 > 3 > 4 > 5.  
 
Figure 1: Free radical reducing potential of compounds 1-5 and standard ascorbic acid as 
evaluated by the spectrophotomeric detection of the Fe3+-Fe2+ transformation (FRAP 
method).  
 
The DPPH radical scavenging assay results are shown in figure 2.  The results revealed that 
the scavenging activity of the standard ascorbic acid was significantly higher than all other 
compounds tested.  At concentrations of 62.5 µg mL-1 and above, the activity decreased in 
the order ascorbic acid > 1 > 2 > 4 > 3, whereas at the lower concentrations, 31.25 and 
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15.625 µg mL-1, nkolbisine (4) had the highest percentage antioxidant activity of 41%.  The 
activity of compounds 1 and 2 was increased with their concentration and significantly 
higher than other compounds, particularly at higher concentrations (Figure 2).  
 
Figure 2: Antioxidant activity of compounds 1-4 and ascorbic acid standard, as  measured 
by the DPPH method.  
 
The hydroxyl radical scavenging activities  in the deoxyribose assay are  shown in figure 3.  
The results revealed that compound 1 possesed significantly higher activity than all the other 
compounds tested, including the standard, ascorbic acid, at most concentrations.  
Compounds 1, 2 and 4 had hydroxyl radical scavenging activity comparable with and in the 
case of 1 and 2, better than that of ascorbic acid.  Skimmianine (5) was not tested in either 
the DPPH or deoxyribose assays due to insufficent amount. 
The three assays revealed that compounds 1 and 2 are good antioxidant compounds, while 
compound 4 shows high activity at a lower concentration in the DPPH assay.  Flavonoids 
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are known to be potent antioxidants and their activity is dependent on their molecular 
structure. The activity of 1 could be attributed to the hydroxyl (OH) groups in the molecule, 
which donate hydrogen  to reduce the DPPH radical to DPPH-H.  The alkaloids 2-5 have the 
same basic skeleton, the only difference being in their side chain. 
 
Figure 3: Hydroxyl radical scavenging activity of compounds 1-4 and standard ascorbic 
acid as measured by the deoxyribose method.  
 
The reductive ability of 2 may be attributed to the double bond of the isoprenyl unit, rich in 
delocalized pi-electrons, which are easily donated during reduction of Fe3+ to Fe2+.  Sang et 
al. also reported that the double bond of the isoprenyl group was responsible for the 
antioxidant activity of garcinol [21].  The antioxidant activity of 2 in the DPPH assay, like 1, 
could also be attributed to the hydroxyl groups in the molecule.  
In conclusion, five compounds were isolated (a flavonoid and four alkaloids) from the aerial 
parts of V. glomerata.  Verification of their antioxidant activities, as well as comparison 
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with known antioxidants, will provide herbalists and traditional healers with scientific 
evidence for the use of the aerial parts of this plant as natural antioxidants.    
Experimental 
General experimental procedures: The melting points were recorded on an Ernst Leitz 
Wetzer micro-hot stage melting point apparatus and are uncorrected.  UV spectra were 
obtained on a Varian Cary UV-VIS Spectrophotometer in chloroform.  IR spectra were 
recorded on a Perkin-Elmer Universal ATR Spectrometer.  The 1D and 2D NMR spectra 
were recorded using a Bruker AvanceIII 400 MHz NMR spectrometer.  All the spectra were 
recorded at room temperature using deuterated chloroform (CDCl3) as solvent.  The 
HREIMS was measured on a Bruker Micro TOF-QII instrument.  Specific rotations were 
measured at room temperature in chloroform on a PerkinElmerTM, Model 341 Polarimeter 
with a 10 mm flow tube.  The separation, isolation and purification of compounds were 
carried out by gravity CC and monitored by TLC.  Merck silica gel 60 (0.040-0.063 mm) 
was used for CC. Merck 20 × 20 cm silica gel 60 F254 aluminum sheets were used for TLC.  
TLC plates were analyzed under UV light (254 and 366 nm) before being sprayed with 
anisaldehyde: concentrated sulfuric acid: methanol [1:2:97] spray reagent and then heated.  
Plant material: Vepris glomerata was collected from the Rift Valley province of Kenya and 
identified by Dr S. T. Kariuki from the Department of Botany, Egerton University, Kenya.  
A voucher specimen (Kiplimo 01) was deposited at the University of KwaZulu-Natal Ward 
Herbarium, Westville Campus, Durban, South Africa. 
Extraction and isolation: The air-dried aerial parts (980 g) of V. glomerata were 
sequentially extracted with n-hexane, followed by dichloromethane in a Soxhlet apparatus 
for 48 h, yielding crude extracts of 46 and 32 g, respectively.  The oily residue of the 
dichloromethane extract obtained after evaporation under vacuum, was separated by CC on 
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silica gel with n-hexane and then increasing the concentration of ethyl acetate from 10 to 
80% in n-hexane, to give 10 fractions (fr.); fr. 8-16 (1.27 g), fr. 17-19 ( 0.5 g), fr. 20-26 
(2.36 g), fr. 27-32 (2.35 g),  fr. 33-39 (1 g), fr. 40-43 (2.1 g), fr. 44-49 (0.5 g), fr. 52-56 (3.9 
g), fr. 57-62 (1.75 g) and fr. 63-67 (5.1 g).  
Fraction 52-56 was separated by CC with n-hexane/EtOAc (7:3) as the solvent to afford 
sub-fractions A-C.  Sub-fraction A was further purified using 100% dichloro-methane to 
afford compound 2, a green solid (51 mg). Sub-fraction B yielded compound 3, a brownish 
solid (43 mg), which needed no further purification.  Sub-fraction C was crystallized in 
methanol to afford 4 (62 mg).  Fraction 44-49 was purified using 100% dichloromethane to 
afford 5 (60 mg). Fraction 63-67 was separated with n-hexane/EtOAc (4:1) to yield 4 sub-
fractions A-D. Sub-fraction B was crystallized in methanol to afford yellow crystals of 
compound 1 (18 mg). 
Veprisinol (1); 4H-1-Benzopyran-4-one, 2, 3-dihydro-5-hydroxy-2-(4’-methoxy-3’-
hydroxylbenzyl)-7-O-(2-methyl butanol) ether. 
Yellow solid.  
M.p: 78-80oC 
[α]20D: +55.30 (c 0.056 CHCl3) 
IR: 3364 (O-H), 2928, 1705 (C=O), 1636, 1512, 1162 cm-1 
UV λmax (CHCl3) nm (log ε): 337 (4.45), 285 (5.13), 239 (5.44) 
1H NMR (400 MHz, CDCl3): 11.97 (H, s, OH), 7.00, (H, s, H-2’),  6.89 (H, d, J = 8.28 Hz, 
H-5’), 6.84 (H, d, J = 8.28 Hz, H-6’), 6.02 (H, d, J = 1.76 Hz, H-6), 6.00 (H, d, J = 1.76 Hz, 
H-8), 5.29 (H, dd, J = 12.84, 2.84 Hz, H-2β), 4.02 (2H, dd, J = 12.88, 6.24 Hz, 2H-1’’), 3.88 
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(3H, s, OCH3), 3.50 (2H, d, J = 5.68 Hz, 2H-4’’), 3.04 (H, dd, J = 17.12, 12.84 Hz, H-3α), 
2.75 (H, dd, J = 17.12, 2.84, Hz, H-3β), 1.87 (2H, m, H-2’’a and H-3’’), 1.61 (H, m, H-
2’’b), 0.95 (3H, d, J = 6.52 Hz, H-5’’). 
13C NMR: 195.97 (C, C-4), 167.29 (C, C-7), 164.05 (C, C-5), 162.85 (C, C-9), 147.02 (C, 
C-4’), 145.93 (C, C-3’),  131.52 (C, C-1’), 118.15 (CH, C-6’), 112.71 (CH, C-2’), 110.71 
(CH, C-5’), 103.11 (C, C-10), 95.54 (CH, C-6), 94.60 (CH, C-8), 78.92 (CH, C-2), 67.86 
(CH2, C-4’’), 66.70 (CH2, C-1’’), 56.06 (OCH3), 43.15 (CH2, C-3), 32.94 (CH, C-3’’), 32.37 
(CH2, C-2’’), 16.60 (CH3, C-5’’).    
HREIMS m/z 388.1573 [M]+ (calcd. for C21H24O7, 388.1522)   
Antioxidant activity: The total reducing power was determined according to the method 
described previously [22].  The free radical scavenging activity (antioxidant capacity) of the 
plant phytochemicals on the stable radical 2, 2-diphenyl-β-picrylhydrazyl (DPPH) was 
evaluated by the method established by Shirwaikar et al. [23], and the deoxyribose assay for 
hydroxyl radical scavenging activity was performed as described previously by Chung et al. 
[24]. 
Statistical analysis: The data in figures 1-3 are presented as mean ± SD of triplicates. a-
dValues  with different superscript letters for a given concentration are significantly diferent 
from each of the other compounds.  The data were statistically analyzed using a statistical 
software program SPSS (SPSS for Windows, version 18, SPSS Science, Chicago, IL, USA).  
One-way analysis of variance (ANOVA) followed by Tukey’s multiple range post-hoc test 
was employed to find the differences.  The data were considered significantly different at p 
< 0.05. 
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Abstract 
A prenylated cinnamaldehyde derivative (glomeral), together with the known p-
hydroxycinnamic acid, caffeic acid, methyl caffeate, hesperetin, scoparone, skimmianine, 
syringaresinol and two limonoids (limonin and limonyl acetate) were isolated from the roots 
and stem bark of V. glomerata.  The antibacterial assay of the isolated compounds indicated 
an inhibition zone, ranging from 8 to 16 mm, against standard strains of Staphylococcus 
aureus (ATCC 29213, 25923) and Shigella dysentrieae.  Glomeral inhibited the growth of 
Staphylococcus aureus and Shigella dysentrieae at low concentrations (MIC of 2 µg mL-1 
and 0.4 µg mL-1 respectively).  Of the other compounds tested, hesperetin displayed good 
antibacterial activity, the limonoids, scoparone and skimmianine displayed moderate 
antibacterial activity and the cinnamic acid derivatives were inactive against the test 
pathogens.  This study provides a rationale for the use of V. glomerata in its treatment of 
bacterial infections.  
Keywords: Vepris glomerata; Rutaceae; glomeral; antibacterial activity. 
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Introduction 
There are about eighty species of the genus Vepris, formerly known as Teclea distributed in 
Tropical Africa, Madagascar, the Mascerenes, Tropical Arabia and Southwest India 
(Chaturvedula et al., 2003).  Vepris glomerata is a small tree that grows to a height of 
approximately 7.5 m.  In Africa it is distributed in the dry bushland of Sudan, Ethiopia, 
Somalia, Kenya and Tanzania (Beentje, 1994).  A decoction of the roots is used traditionally 
in the treatment of malaria, whilst the vapour is used to treat eye problems.  A decoction of 
the bark is used in the treatment of cardiac pain while epilepsy, stroke and psychosis is 
treated using an aqueous root extract of the plant mixed with tea (Innocent et al., 2009; 
Moshi et al., 2006). 
Previous investigations of Vepris species indicated that it is rich in furoquinoline alkaloids 
(Govindachari and Sundararajan, 1961; Ganguly et al., 1966; Rudolf and Eva Maria, 1978; 
Dagne et al., 1988; Chaturvedula et al., 2003), acridone alkaloids (Rasoanaivo et al., 1999), 
pyranoquinoline alkaloids (Brader et al., 1996), triterpenoids and sesquiterpenoids (Khalid 
and Waterman, 1982; Chaturvedula et al., 2004), limonoids (Ngadjui et al., 1982; Cheplogoi 
et al., 2008), azoles and imides (Cheplogoi et al., 2008) and essential oils (Sidibe et al., 
2001; Poitou et al., 1995; Denise and Favre-Bonvin, 1973).  
With regard to V. glomerata, only one phytochemical study has been undertaken where two 
furoquinoline alkaloids (skimmianine and montrifoline) have been isolated from the aerial 
parts of V. glomerata indigenous to Ethiopia (Dagne et al., 1988).  In terms of 
pharmacological activity, the ethanolic crude extract of V. glomerata collected from Tabora 
(Tanzania) exhibited antimalarial activity against Plasmodium berghei (Innocent et al., 
2009).  The current study was undertaken primarily to re-investigate the phytochemistry of 
V. glomerata since only two alkaloids were previously found and to test the isolated 
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compounds for antimicrobial activity since extracts of Rutaceae species have been cited as 
antimicrobials in traditional medicine (Kokwaro, 1976).  Furthermore, limonoids which 
were isolated in this work are reported to have antifungal activity (Govindachari et al., 
1998) and natural phenyl propanoids to which compounds 1-4 are structurally related are 
well known antibacterial agents (Jimenez and Riguera, 1994).  This is the first 
phytochemical investigation of the roots and stem bark of V. glomerata.  
Results and discussion   
Of the two furoquinoline alkaloids previously isolated, only skimmianine (7) (Latip et al., 
2005) was isolated in this work.  Montrifoline was not detected in the stem bark and roots 
and may be confined to the aerial parts of the plant.  Several other compounds, including a 
new prenylated cinnamaldehyde derivative (glomeral 1), known aromatic acids, (p-
hydroxycinnamic acid 2 and caffeic acid 3 (Lu et al., 1999)), an aromatic ester (methyl 
caffeate 4 (Lu et al., 1999)), a flavonoid (hesperetin 5 (Wawer and Zielinska, 2001)), a 
coumarin (scoparone 6 (Lee et al., 2002)), a lignin  (syringaresinol 8 (Ouyang et al., 2007)), 
and two limonoids (limonin 9 (Khalil et al., 2003) and limonyl acetate 10 (Ruberto et al., 
2002)) (Figure 1) were isolated from the stem bark and roots of V. glomerata. Compounds 
2-10 were identified by their 1H and 13C NMR spectra and by comparison with 


































2. R1 = H, R2 = OH, R3 = H
3. R1 = OH, R2 = OH, R3 = H
4. R1 = OH, R2 = OH, R3 = CH3  
 









































































































8. Syringaresinol 9. R1 = O (Limonin)
10. R1 = OAc (Limonyl acetate)
 
Figure 1: Structures of compounds isolated from Vepris glomerata 
The HREIMS data of compound (1) showed a molecular ion peak at m/z 263.1278 [M+H]+, 
corresponding to the molecular formula of C15H18O4 and indicating seven double bond 
equivalents.  The IR spectrum of compound 1 revealed the presence of OH and carbonyl 
stretching frequencies at 3348 cm-1 and 1713 cm-1 respectively.  The 1H NMR spectrum of 
compound 1 showed characteristic resonances for prenylated cinnamaldehydes with 
resonances at δH 6.57 (1H, dd, J = 15.80, 7.74 Hz), δH 7.37 (1H, d, J = 15.80 Hz) and δH 
9.59 (1H, d, J = 7.74 Hz), with the large coupling constant of 15.80 Hz indicative of trans 
olefinic protons and were attributed to H-2, H-3 and the aldehyde proton, H-1, respectively.  
This coupling was also evident in the COSY spectrum. 
An ABX coupled system could be seen in the second proton system, which consisted of a 
triplet at δH 4.74 (1H, t, J = 9.15 Hz, H-2’), which coupled in the COSY spectrum to the two 
 
P a g e  | 115 
doublet resonances at δH 3.18 and δH 3.21, H-1’a and H-1’b, both with J = 9.15 Hz.  The H-
1’a and H-1’b resonances occurred separately, since these were diastereotopic protons.  The 
two methyl resonances at δH 1.34 and δH 1.24 showed HMBC correlations to the C-2’ 
methine carbon resonance at δC 91.09 and a quaternary carbon resonance at δC 71.74, C-3’.  
These COSY and HMBC correlations indicated the presence of a prenyl group with an 
epoxide ring at C-2’ and C-3’, also confirmed by the molecular mass of the compound.  
Also present in the 1H NMR spectrum were two aromatic resonances at δH 6.91 and δH 7.02 
and an aromatic methoxy proton resonance at δH 3.93.  Apart from the C-6 resonance, a 
further deshielded aromatic C-O resonance was detected at δC 151.23 indicating the 
presence of a further aromatic hydroxyl group.  The fifteen carbon resonances detected in 
the 13C NMR spectrum indicated that the substituents on the benzene ring were the 
cinnamaldehyde group, the prenyl group, the two aromatic hydrogen atoms, the methoxy 
and hydroxyl group.  The prenyl group was placed at C-8 because 2H-1’ showed an HMBC 
correlation to C-9.  The remaining hydroxyl group was then placed at C-7.  
The absolute configuration of glomeral (1) was established by the CD spectrum which 
showed a positive cotton effect at 328 nm (∆ε +3.0) due to the n→π* transition of the 
carbonyl group, a negative cotton effect at 292 nm (∆ε -0.5) due to the π→π* transition of the 
double bond and a positive cotton effect at 218 nm (∆ε +6.5) due to the π→π* transition of 
the α, β unsaturated aldehydic carbonyl group.  The configuration of the chiral carbon C-2’ 
was established to be R  and the compound identified as 3-[3-(3-methyl-(2R)-2,3-epoxy-
butyl)-4-hydroxy-5-methoxyphenyl]-propenal in comparison with the CD spectrum of methyl 
12,14-dihomojuvenate which was determined to be (E,E)-(10R,11S)-10,11-epoxy-7-ethyl-
3,11-dimethyl-2,6-tridecadienoate (Meyer et al., 1971).   
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This is the first report of compound 1 and has been given the trivial name glomeral. 
Glomeral (1) shared high structural resemblance to 3-(3-methyl-2-epoxy-butyl-)-P-coumaric 
acid methyl ester isolated from Psoralea plicata (leguminosae) except that glomeral (1) has 
an additional methoxy group at C-6 as well as the cinnamaldehyde group at C-4 instead of 
the ester group (Hamed et al., 1997). 
The antibacterial results of the pure compounds (1, 5, 6, 7, 9 and 10) indicate a broad 
spectrum activity against the test organisms Staphylococcus aureus (ATCC 29213 and 
25923) and Shigella dysentrieae (Table 1).  No results were recorded for Escherichia coli 
and the fungal strains investigated since all compounds tested were inactive against these 
microbes.  Compounds 2-4 and 8 were also inactive against all tested strains and therefore 
the results are not included in the table.  The inhibition zone determination shows that the 
new compound, glomeral (1) exhibited good activity with inhibition zones of 16 mm against 
S. dysentrieae, and 15 mm and 14 mm against S. aureus (ATCC 29213) and S. aureus 
(ATCC 25923) respectively.  Hesperetin (5) and scoparone (6) also showed good activity 
with inhibition zones of between 9 and 14 mm against S. dysentrieae and the two cultures of 
S. aureus.  The observed results for these compounds were comparable with that of 
chloroamphenicol with an inhibition zone of 20 mm against S. aureus and 18 mm against S. 
dysentrieae.  The remaining compounds (skimmianine (7), limonin (9), and limonyl acetate 
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Glomeral  1 15 ± 1.0 14 ± 1.2 16 ± 1.0 2 2 0.4 
Hesperetin 5 12 ± 1.3 11 ± 1.0 14 ± 1.1 0.2 0.2 4 
Scoparone 6 10 ± 1.1 09 ± 1.5 16 ± 1.6 16 16 0.2 
Skimmianine 7 09 ± 1.2 06 ± 1.2 10 ± 1.3 16 >32 16 
Limonin 9 08 ± 1.6 07 ± 1.3 08 ± 1.4 >32 >32 16 
Limonin acetate 10 08 ± 1.4 08 ± 1.2 10 ± 1.5 >32 >32 32 
Chloroamphenicol 20 ± 1.0 20 ± 1.3 18 ± 1.7 2 2 8 
Key: S.a –Staphylococcus aureus, S.d - Shigella dysentrieae  
The minimum inhibitory concentration (MIC) determination (Table 1) showed that 
hesperetin (5) completely inhibited the growth of S. aureus (ATCC 29213 and ATCC 
25923) and S. dysentrieae, at low concentrations of 0.2 µg/mL and 4.0 µg/mL respectively, 
even lower than that of chloroamphenicol.  The MIC value of glomeral was the same as that 
of chloroamphenicol for S. aureus at 2.0 µg/mL and twenty times lower (0.4 µg/mL) than 
chloroamphenicol against S. dysentrieae.   Scoparone (6) was the most active of all the 
compounds tested against S. dysentrieae at 0.2 µg/mL being forty times lower than that of 
chloroamphenicol in the same assay.  The rest of the compounds (7, 9 and 10) had MIC 
values of either 16 µg/mL or greater than 32 µg/mL. 
These results are consistent with previous findings that showed phenyl propanoid 
derivatives (which are structurally related to glomeral) isolated from Ballota nigra 
(Lamiaceae) to possess moderate activity against S. aureus (Didry et al., 1999).  
Experimental 
3.1 General experimental procedures.  The 1H, 13C and all 2D NMR spectroscopy were 
recorded using a Bruker AvanceIII 400 MHz spectrometer.  The spectra were referenced 
according to the deuteriochloroform signal at δH 7.24 (for 
1H NMR spectra) and δC 77.0 (for 
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13C NMR spectra).  The HREIMS was measured on Bruker Micro TOF-QII instrument.  IR 
spectra were recorded using a Perkin Elmer Universal ATR spectrometer. Optical rotations 
were measured at room temperature in a PerkinElmerTM, Model 341 Polarimeter with 10 
cm flow tube.  The Circular Dichroism (CD) spectrum was recorded on chirascan plus 
spectropolarimeter by applied photophysics at wavelengths 190-400 nm.  The melting points 
were determined on an Ernst Leitz Wetziar micro-hot stage melting point apparatus.  Merck 
silica gel 60 (0.040-0.063 mm) was used for column chromatography and Merck 20 × 20 cm 
silica gel 60 F254 aluminium sheets were used for thin-layer chromatography.  The TLC 
plates were analysed under UV (254 and 366 nm) before being sprayed and developed with 
a [1:2:97] anisaldehyde: concentrated sulphuric acid: methanol spray reagent and then 
heated.  
3.2 Plant material.  The stem bark and roots of V. glomerata were collected in December, 
2009 in Rift Valley Province of Kenya.  The plant was identified by Dr S. T. Kariuki of the 
Department of Botany, Egerton University.  A voucher specimen (Kiplimo 01) has been 
retained at the University of KwaZulu-Natal Ward Herbarium, Westville, Durban. 
3.3 Serial extraction and isolation.  The air-dried and ground plant material of V. glomerata 
(823.3 g stem bark and 719.3 g roots) was sequentially extracted for 24 hours using a 
soxhlet apparatus with solvents of increasing polarity; hexane, dichloromethane, ethyl 
acetate and methanol.  The collected solution of each extract was individually evaporated 
using a rotavapor.  
Crude extracts were loaded onto a column (4.5 in diameter) packed with a silica gel slurry to 
a height of 30 cm.  For each elution system 2 L volumes were used and 100 mL fractions 
collected.  The collected fractions were analysed using TLC to determine if separation had 
occurred. Similar fractions were combined and concentrated using a rotavapor.   
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The dichloromethane extract from the roots was separated with a hexane: ethyl acetate step 
gradient starting from 100% hexane to 80% ethyl acetate in hexane.  The following fractions 
were combined and purified using the given solvent  systems; 19-28 (hexane: ethyl acetate, 
80:20) which yielded  glomeral (1) (56 mg), 52-55 ( hexane: ethyl acetate, 70:30) which 
yielded scoparone (6) (19.7 mg), 60-70 (dichloromethane: ethyl acetate, 80:20) yielded 
skimmianine (7) (23 mg), 85-92 (dichloromethane: ethyl acetate, 70:30) yielded meso-
syringaresinol (8) (5.3 mg). 
The ethyl acetate extract from the stems yielded compounds 2-5.  The mobile phase in the 
crude separation consisted of a hexane: ethyl acetate step gradient.  Compound 5 (19.3 mg) 
was obtained from fraction 36-39 and further purified with (70:30) hexane: ethyl acetate. 
Trans-p-hydroxy cinnamic acid compound 2 (9.2 mg) was obtained from fraction 27-31 and 
purified by 100% dichloromethane.  Compound 3 (22.3 mg) was obtained from fraction 84-
93 and purified with a 1:1 ratio of ethyl acetate and hexane.  Fraction 40-48 was purified by 
30% ethyl acetate in dichloromethane to yield compound 4 (11.3 mg). 
The dichloromethane extract of the stems afforded two limonoids, after the crude extract 
was separated using a hexane: ethyl acetate step gradient.  Both were obtained from 
fractions 32-49 using hexane: ethyl acetate (70:30).  Fraction 32-45 was purified using 
hexane: ethyl acetate, 80:20 to afford limonin, 9 (21 mg).  Fraction 46-49 was purified with 
100% dichloromethane which yielded limonyl acetate 10 (33 mg).  
3.3.1  Glomeral (1) reddish brownish solid; mp 58-60 oC; [α]20D  +27.8° (c 0.016, CHCl3); 
UV λmax  (CHCl3)  nm (log ε) 253 (1.92); IR (cm
-1): 3348 (-OH), 2927 (-CHO), 2854, 1713 
(>C=O), 1616, 1490;  1H NMR spectral data ( 400 MHz, CDCl3)  δH  9.59 (1H, d,  J = 7.80 
Hz, H-1), 7.37 (1H, d,  J = 15.80 Hz,  H-3),  7.02 (1H, s*, H-9), 6.91 (1H, s*, H-5), 6.57 
(1H, dd, J = 15.80, 7.80 Hz, H-2), 4.74 (1H, t,  J = 9.15,  Hz, H-2’), 3.93 (3H, s, OCH3),  
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3.18 (1H, d, J = 9.15 Hz,  H-1’a), 3.21 (1H, d, J = 9.15 Hz,  H-1’b), 1.35 (3H, s, CH3-5’), 
1.21 (3H, s, CH3-4’); 
13C NMR spectral data  (100 MHz, CDCl3)  δC 193.74 (C-1), 153.38 
(C-3), 151.23 (C-7), 144.46 (C-6), 129.37 (C-8), 127.88 (C-4), 126.28 (C-2), 118.69 (C-9), 
111.57 (C-5), 91.09 (C-2’), 71.74 (C-3’), 56.05 (OCH3), 30.64 (C-1’), 26.12 (C-5’), 24.18 
(C-4’); EIMS (70 eV)  m/z (rel. int): 262 [M+] (100), 229 (13), 203 (30), 191 (13), 173 (24), 
161 (15), 115 (17); HREIMS (70 eV) 263.1254 [M+1]+ (Calc. for C15H19O4). 
*These resonances were not resolved into doublets with J = 2-3 Hz as expected for meta 
coupling, however the resonances were slightly broadened and also coupled in the COSY 
spectrum,  indicating meta coupling. 
3.4 Antimicrobial assay.  Gram-negative bacteria, Escherichia coli and Shigella 
dysentrieae, and Gram-positive bacteria, Staphyloccocus aureus ATCC 29213 and ATCC 
25923 were used for the antibacterial assay and fungal strains, Candida albicans, Candida 
parapsilosis, Cryptococcus neoformans and Trichophyton mentagrophytes were used for the 
antifungal assay.  The bacterial and fungal strains were cultured for 18 hours at 37 oC on 
Muller Hinton agar (and saboraud dextrose agar for fungi) and standardized to a final cell 
density of 1.5x108 cfu/ml using a barium sulphate standard equivalent to McFarland No. 0.5 
standard or its optical equivalent.  
Disc diffusion method: Blank discs were sterilized by air drying at 160 oC for 1 h.  Test 
compounds were dissolved in DMSO and 20 µl of the solution (compound and DMSO) 
impregnated onto the blank sterile discs and placed asceptically onto the inoculated petri 
dish, which were then incubated at 37 oC for 24 hours for the bacteria while the fungi were 
incubated for 72 hours at 25 oC.  The activity of the compounds was determined by the 
presence of measureable inhibition zones. 
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Broth microdilution method (Andrews, 2001): The test compounds and the standard 
chloroamphenicol (fluconazole for the fungi) were dissolved in dimethyl sulfoxide (DMSO) 
to a concentration of 10 mg/ml.  Serial two fold dilutions were made ranging from 0.002 
µg/ml to 32 µg/ml in sterile test tubes.  The 96-well plates were prepared by dispensing into 
each well, 90 µl Muller Hinton and 10 µl of the bacterial inoculums.  The first three wells 
containing Muller Hinton broth were used as a negative control and the next three 
containing 90 µl Muller Hinton broth and 10 µl of the bacterial inoculums without the test 
compound were used as growth control.  The standard antibiotic tetracycline was used as a 
positive control.  The plates were covered to avoid contamination and evaporation and 
incubated for 24 hours at 37 oC.  All procedures were done in triplicate. The lowest 
concentration of each compound showing no visible growth was taken as its minimum 




The phytochemical analysis of V. glomerata showed the existence of the antimicrobial 
compounds, glomeral (a new cinnamaldehyde), hesperetin and scoparone.  Skimmianine, 
limonin and limonyl acetate showed low to moderate antibacterial activity.  These results 
provide scientific validity and credence to the ethnomedicinal use of this plant in the 
treatment of ailments caused by some of the pathogenic microbes used in this study and 
highlights the efficacy of V. glomerata in the treatment of bacterial infections.  Further 
studies on structure-activity relationships and mode of action may be a guide to a better 
understanding of the relationships between the structures and antimicrobial activities of 
these compounds. 
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CHAPTER SIX 
RING A, D-SECO LIMONOIDS AND FLAVONOID FROM 
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ABSTRACT 
Two new A, D-seco-limonoids, accorded the trivial names, uguenensene (4) and 
uguenensone (5) and a new C-7 prenylated flavonoid, uguenenprenol (8) were isolated from 
Vepris uguenensis (Rutaceae).  In addition, eleven known compounds, niloticin (1), 
chisocheton A (2), kihadalactone A (3), limonyl acetate (6), methyl uguenenoate (7), 7-O-
methylaromadenrin (9), flindersiamine (10), 8α,11-elemodiol (11), tricoccin S13 acetate, 
skimmianine, and lupeol were isolated.  The structures of the new compounds were 
elucidated and characterized by spectroscopic analyses (NMR, GC-MS and IR).  
Antioxidant activity of the isolated compounds using the 2,2-diphenyl-β-picrylhydrazyl 
(DPPH), Deoxyribose and Ferric Reducing Antioxidant Power (FRAP) assays showed that 
uguenenprenol (8) and 7-O-methylaromadenrin (9) are good antioxidant agents.  
Significantly high antioxidant activity was also exhibited by 8α,11-elemodiol (11), which 
was 72% at 250 µg mL-1 and 57% at 15.62 µg mL-1 when tested with the Deoxyribose 
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method.  The current contribution adds uguenensene (4) and uguenensone (5) to the class of 
citrus limonoids common to the Rutaceae which can be used not only for medicinal 
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Limonoids are tetranortriterpenoids derived from the acetate-mevalonate pathway with the 
triterpenoids euphane or tirucallane being the key intermediates1,2.  Citrus limonoids have 
been shown to originate from nomilin which is biosynthesized in the phloem region of stems 
and then migrate to other tissues such as leaves, fruits and seeds, where other limonoids are 
biosynthesized3.  Limonoids are the main constituents of the Rutaceae and are known to 
have a wide range of biological activities.  The biological activities of limonoids have 
attracted widespread scientific interest; they are reported to exhibit antifungal4, 
antibacterial5, antimalarial6, antifeedant7, antiprotozoan8, antiviral9 and anti-inflammatory10 
activities, and recently, the antioxidant capacity of citrus limonoids and limonoid-containing 
extracts have been evaluated using the racimat experiment, superoxide radical quenching 
and the DPPH radical scavenging assays11.  Limonoids have also been known to inhibit the 
development of cancer in laboratory animals and in human breast cancer cells12.  
The plant Vepris uguenensis is known as ‘Chemchir’ by the Pokot tribe of Kenya, who use 
it to treat malaria13.  Previous phytochemical reports indicated that a limonoid (methyl 
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uguenenoate), an azole (uguenenazole) and an imide (uguenenonamide) were isolated from 
the roots of V. uguenensis13.  Methyl uguenenoate displayed mild antimalarial activity while 
the azole and the imide were found to be completely inactive13.  No phytochemical 
compounds from the stem bark and leaves of V. uguenensis have been reported thus far.   
Oxidative stress is a situation where there is an imbalance between the production of 
reactive oxygen species (ROS) that can damage cell structures and the body's ability to 
detoxify these molecules or repair the resulting damage.  These reactive oxygen species 
(ROS) have been found to mediate neurological injury in cerebral malaria (CM) which is the 
most severe neurological complication of infection with Plasmodium falciparum14.  During 
an attack of malaria, the parasite breaches the blood–brain barrier to cause cerebral malaria 
(CM), resulting in a life-threatening crisis14.  With suitable treatment, patients do recover 
but often do so with lasting damage to their brain, resulting in a loss of mental function14.  
Studies have shown that the lives of many African children have been shattered in this way.  
It is reported that 21% of children with CM had cognitive deficits six months after discharge 
from hospital in Uganda15.  This is because cerebral malaria leads to increased production of 
molecules indicative of oxidative stress in the brain14.  Treatment with a combination of 
chloroquine and two antioxidant agents, desferoxamine and N-acetylcysteine, at the first 
signs of cerebral malaria prevents both inflammatory and vascular changes in the tissues of 
the brain, as well as the development of persistent cognitive damage14.  The addition of 
antioxidants does not weaken the efficacy of chloroquine in eliminating Plasmodia from the 
blood.  Combination therapy with antioxidants has been effective in treating cerebral 
malaria and preventing subsequent cognitive impairment in mice14. 
Since V. uguenensis is used as an antimalarial in African traditional medicine, and 
limonoids are reported to possess antioxidant activity11, all the isolated compounds were 
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subjected to antioxidant assays using the ferric reducing antioxidant power (FRAP), the 2,2-
diphenyl-β-picrylhydrazyl (DPPH) and the deoxyribose methods.  We present herein the 
details of the isolation and structure elucidation of three new compounds, a C-7 prenylated 
flavonoid (8) and two limonoids (4 and 5) as well as the in vitro antioxidant activities of the 
isolated compounds and a brief discussion on the biogenetic relationship of the limonoids 
(1-7).  
RESULTS AND DISCUSSION 
Repeated column chromatography of the hexane and dichloromethane extract of the leaves, 
stem bark and roots yielded eleven known compounds; a triterpenoid (lupeol), a 
sesquiterpene (8α,11-elemodiol (11)), two furoquinoline alkaloids (skimmianine and 
flindersiamine (10)), a flavonoid (7-O-methylaromadenrin (9)), two proto-limonoids 
(niloticin (1) and chisocheton A (2)) and four limonoids (tricoccin S13 acetate, kihadalactone 
A (3), limonyl acetate (6) and methyl uguenenoate (7)).  A further two novel A, D-seco 
limonoids and a prenylated flavonoid, which were accorded the trivial names; uguenensene 
(4), uguenensone (5) and uguenenprenol (8) were isolated.  Structures of known compounds 
were determined using NMR and MS techniques and confirmed by comparison of physical 
and spectroscopic properties against literature data16-21.  
The isolated compounds (1-7) displayed an interesting limonin biogenetic sequence with 
structural features expected of intermediates in the limonin biosynthetic pathway (Figure 1). 
According to the generally accepted scheme, the ∆7 bond as in niloticin (1), is epoxidized to 
the 7-epoxide and then opened, inducing a Wagner-Meerwein shift of the methyl group at 
C-14 to C-8 leading to the formation of a double bond at ∆14 in 2, together with modification 
of the side chain2.  This is followed by side chain cleavage of the four carbon epoxide group 
and the expansion of the carbocyclic A-ring in 2 to a seven membered δ-unsaturated lactone 
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ring as seen in tricoccin S13 acetate.  Reduction of the side chain lactone ring to form the 
furan ring, as well as acetylation at C-1 results in 3.  Contraction of ring A to a five 
membered ring and lactonization involving the methyl group (CH3-19) and the carbonyl 
group at C-3 leading to the formation of A and A’ rings (A-seco), occurs with a concurrent 
epoxidation at ∆14, producing 4. Ring contraction and lactone formation may occur 
simultaneously.  Oxidation at C-16 results in 5, which is followed by a Baeyer-villager 
oxidation of the D ring to a lactone resulting in 6.  Methanolysis of the A ring lactone results 
in 7.  Figure 1 shows the postulated biogenetic pathway for the formation of the proto-
limonoids and limonoids 1-7, with 4 and 5 taking its place in the biosynthetic scheme. 
Compound 4 was isolated as a reddish brown solid and had a molecular formula of 
C28H36O7 as determined by HREIMS, with a molecular ion M
+ at m/z 484.2461 (as 
expected) indicating 11 degrees of unsaturation.  The IR spectrum showed the presence of 
carbonyl (C=O) stretches at 1733 and 1739 cm-1; epoxide (C-O) stretches at 1231 cm-1 and 
β-substituted furan ring C-H bending vibrations at 726 cm-1.  The 1H NMR data (Table 1) 
indicated the presence of a characteristic epoxy group methine proton at δH 3.39 (s, H-15) 
and oxygenated protons at δH 4.01 (d, J = 3.96 Hz, H-3), δH 4.71 (t, J = 2.2 Hz, H-7), δH 
4.49 (d, J = 13.21 Hz, H-19 exo) and δH 4.34 (d, J = 13.21 Hz, H-19 endo).  The acetyl 
methyl proton resonance occurred at δH 2.06.  The three furan proton resonances occurred at 
δH 7.07 (s, H-21), 6.11 (s, H-22) and 7.33 (s, H-23), with the corresponding carbon 
resonances of H-21 and H-22 showing HMBC correlations to a methine proton resonance at 
δH 2.57 (dd, J = 11.25, 6.04 Hz), attributed to H-17.  Beside the methyl acetate, there were 
four other tertiary methyl resonances at δH 0.88 (3H-30), 0.95 (3H-18), 1.20 (3H-29) and 
1.07 (3H-28).  The position of the methyl groups were supported by HMBC data; 3H-28 and 
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3H-29 with C-4 and C-5; 3H-18 with C-14, C-13 and C-12; 3H-30 with C-7, C-8 and C-9.  
The methine proton at δH 3.39 (s, H-15) showed HMBC correlations with C-16 and C-17.   
Cyclisation between C-19, and C-3 which incorporated C-1 and C-2 was supported by 2D 
NMR correlations.  The H-3 and both H-19 doublets (H-19 endo and exo) showed HMBC 
correlations to the carbonyl resonance of C-1 and the formation of the lactone ring was 
further supported by HMBC correlations between H-3 and both C-19 and C-9.  The H-19 
doublets also showed HMBC correlations to C-5, C-9 and C-10 as expected and to C-3, only 
possible with cyclisation between C-19 and C-3. 
The selected 1D gradient NOE (GOESY) experiments on compound 4 revealed a twist in 
the rearranged A-ring structure; this twist is clear in a 3-D model.  NOE correlations were 
observed between H-9 and H-5, H-3 and 3H-18, which were on the backface in the 3-D 
model.  The methyl group 3H-30 showed NOE correlations to H-7, H-6β, H-11β, and H-
19exo; these were on the top face in the 3-D model.  This results in H-19 endo being 
situated proximal to the 4β methyl (3H-29) and H-6β. The H-17β resonance exhibited NOE 
correlations with the furanyl protons H-21 and H-22 and the H-16β proton resonances.  
The absolute configuration was determined by circular dichroism (CD).  The CD spectrum 
of 4 showed a positive cotton effect at 197 nm (∆ε +8.5) and a negative cotton effect 210 
nm (∆ε -22.0).  The furan chromophore (λmax 206 nm) was probably masked by the cotton 
effect of the ester and lactone groups.  A positive cotton effect was also observed at 328 nm, 
(∆ε +1.2) due to the n→π* transition of the carbonyl groups of 4 and was in accordance 
with the CD spectra observed for limonoids from Turraea pubescens22.  The 
stereochemistry of the epoxide was shown to be β, in accordance with the orientation 
previously described for limonoids with a ∆14, epoxide23,24.  The absolute configuration of 
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the ten chiral centers in 4 was thus determined as 3R, 5R, 7R, 8R, 9R, 10S, 13R, 14R, 15R 
and 17R. 
The spectroscopic data and functionalities established that compound 4 was an A, D-seco 
limonoid, which are common to the Rutaceae and rare in the Meliaceae25.  Ring D 
resembled evodulone isolated from Carapa procera21, whereas ring A resembled limonin 
(A, A’ ring system).  The other two rings, B and C of compound 4 remained carbocyclic.  
Comparison of the 1H NMR data of compound 5, a brown solid with that of compound 4, 
indicated the notable absence of the methylene protons, H-16α and H-16β, which occurred 
at δH 2.13 and δH 1.59 in 4.  This occurred with an additional carbonyl resonance at δH 
208.5, indicating that a ketone functionality was now present at position 16.  This was 
supported by the HREIMS, which showed a molecular ion peak at m/z 498.9120 for 
C28H34O8, two hydrogen atoms less and one oxygen atom more than 5.  The presence of the 
carbonyl functionality at C-16 also affected the proton and carbon chemical shifts at 
position 17, shifting them downfield to δH 3.81 from 2.57 and to δC 50.85 from 39.63.  The 
relative stereochemistry of 5 was deduced to be the same as that of 4 based on their almost 
superimposable 1H and 13C NMR data and similar NOESY and NOE correlation patterns to 
those of 4.  The Absolute configuration of 4 and 5 were also identical as indicated by similar 
CD curves.  
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Table 1. NMR spectroscopic Data (400 MHz, CDCl3) for uguenensene (4) and uguenensene (5) 
aHMBC- correlations are from proton(s) to the indicated carbon (H→C) 
 
Compound 8 was identified as a flavanone by its NMR, UV, IR and mass data.  Its 
molecular formula was established to be C20H20O7 based on HREIMS data of 372.1158 amu 
with a double bond equivalence of 11, eight being due to the aromatic rings, one being due 
  uguenensene (4)   uguenensone (5) 
Position δC, type δH (J in Hz) HMBC
a
 δc, type δH (J in Hz) 
1 169.94, C - - 169.80, C - 
2α 35.95, CH2 2.92, dd (16.48, 3.96) 1, 3 35.92, CH2 2.93, dd (16.56, 3.96) 
2β - 2.60, d (16.48) 1, 3 - 2.62, d (16.56) 
3 80.26, CH 4.01, d ( 3.96) 1, 9, 19 80.07, CH 4.01, d (3.96) 
4 80.58, C - - 80.60, C - 
5 54.19, CH 2.22, m 3, 4, 10,  
19, 28, 29 
54.16, CH 2.21, dd (13.48, 3.08) 
6 α 24.41, CH2 1.81, m 5  24.27, CH2 1.84, m 
6β - 1.72, m - - 1.78, m 
7β 73.53, CH 4.71, t (2.20) 5, 9, 31 73.35, CH 4.66, t (2.36) 
8 42.79, C - - 43.10, C - 
9 44.03, CH 2.79, dd (11.8, 4.20) 3, 8, 11, 19 43.31, CH 2.84, dd (13.20, 4.72) 
10 45.62, C - - 45.58, C - 
11α 18.55, CH2 1.96, m - 18.27, CH2 1.95, m 
11β - 1.71, m - - 1.76, m 
12 α 29.64, CH2 1.83, m - 28.30, CH2 2.19, m 
12 β - 1.80, m - - 1.73, m 
13 41.82, C - - 42.50, C - 
14 72.40, C - - 71.62, C - 
15 57.58, CH 3.39, s 16, 17 57.29, CH 3.34, s 
16 α 31.95, CH2 2.13, dd (13.35, 6.04) 13, 14,15, 17 208.05, C - 
16 β - 1.59, dd (13.35, 11.25) 17 - - 
17 39.63, CH 2.57, dd (11.25, 6.04) 12, 13, 16,  
18, 20, 21,22  
50.85, CH 3.81, s 
18 21.36, CH3 0.95, s 12, 13,  
14,17 
24.21, CH3 1.02, s 
19 exo 66.04, CH2 4.49, d (13.12) 1, 3, 5, 10 65.85, CH2 4.50, d (13.08) 
19 endo - 4.34, d (13.12) 5, 9 - 4.36, d (13.08) 
20 123.46, C - - 116.27, C - 
21 139.57, CH 7.07, s 20, 22, 23 141.60, CH 7.50, s 
22 110.85, CH 6.11, s 20, 21, 23 110.84, CH 6.17, s 
23 143.01, CH 7.33, s 20, 21, 22 142.56, CH 7.35, s 
28 21.36, CH3 1.07, s 4, 5, 29 21.25, CH3 1.06, s 
29 30.17, CH3 1.20, s 4, 5, 28 30.14, CH3 1.19, s 
30 19.38, CH3 0.88, s 7, 8, 9, 14 19.39, CH3 0.96, s 
31 
OCOCH3 
169.55, C - - 169.50, C - 
32 
OCOCH3 
21.37, CH3 2.06, s 31 21.32, CH3 2.01, s 
 
P a g e  | 136 
to the carbonyl group, one due to the double bond on the side chain and the remaining one 
being due to ring C of the flavanone skeleton.  The IR data showed the presence of O-H 
(3330 cm-1), and C=O (1708 cm-1) stretching bands.  The 1H NMR data showed a 
characteristic AB coupling system of H-2 and H-3 which appeared at δH 4.58 (1H, d, J = 
11.65 Hz, H-2) and δH 4.82 (1H, d, J = 11.65 Hz, H-3), which was supported by COSY 
correlations between the two resonances.  Their coupling constants were characteristic of 
trans protons26, and this trans stereochemistry was confirmed by NOESY correlations 
between H-3 and H-2’/6’.  
The second characteristic pattern was that of an AA’BB’ system of a 1,4-disubstituted 
aromatic ring (ring B).  These proton resonances occurred as two doublets at δH 7.36 (2H, d, 
J = 8.52 Hz, H-2’/6’), and δH 6.85 (2H, d, J = 8.52 Hz, H-3’/5’).  COSY coupling between 
H-2’/6’ and H-3’/5’ were also observed. Also present in the 1H NMR data were two 
aromatic protons at δH 6.09 (1H, d, J = 2.2 Hz, H-6) and δH 6.04 (1H, d, J = 2.2 Hz, H-8) 
attributed to ring A.  The observed coupling constant of 2.2 Hz was indicative of meta 
coupling.  
The third pattern was that of the isoprenol group in ring A.  The 2H-1’’ and H-2’’ 
resonances were observed at δH 4.66 (2H, d, J = 6.32 Hz, H-1’’) and δH 5.70 (1H, t, J = 6.32 
Hz, H-2’’).  A singlet was also observed at δH 3.76 attributed to 2H-4’’, which showed 
HMBC correlations to the quaternary carbon resonance at δC 142.04 (C-3’’), the methine 
carbon resonance at δC 119.65 (C-2’’) and the methyl carbon resonance at δC 14.03 (C-5’’).  
These correlations indicated that one of the methyl protons in an isoprenyl unit had been 
oxidized to a primary alcohol and that the isoprenyl group was attached to C-7 by an ether 
linkage as the 2H-1’’ resonance was seen to be deshielded. 
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The isoprenol group was placed at C-7 since H-6 and H-8 both showed NOESY correlations 
with 2H-1’’.  This would not be possible if the isoprenol group was located at C-5.  The 
hydroxyl groups were thus placed in the remaining C-4’, C-3 and C-5-positions, which are 
also the most common positions to be hydroxylated.  The carbon resonances of δC 165.02 
(C-4’), 85.10 (C-3) and 164.36 (C-5) support these assignments.  
The absolute configuration of C-2 and C-3 were determined by CD analysis in comparison 
with literature values26,27.  The CD spectrum showed a positive cotton effect at 205 nm, ∆ε 
+8.8, (π→π* for the double bond), 290 nm, ∆ε +4.0 (π→π*) and 335 nm, ∆ε +2.0 (n→π* of 
the carbonyl group).  The absolute configuration of the chiral centers was assigned as 2R, 
3R. Compound 8 was thus identified as (2R,3R)-3,5-dihydroxy-7-((E)-4-hydroxy-3-
methylbut-2-enyloxy)-2-(4-hydroxyphenyl)chroman-4-one. 
Eleven of the fourteen compounds isolated, were evaluated for their antioxidant potentials 
using three different antioxidant assays; FRAP, DPPH and deoxyribose methods.  Two of 
the compounds, tricoccin S13 acetate and skimmianine were not tested for their antioxidant 
activity as they were isolated in very small quantities, 23 mg and 13 mg respectively.  Only 
compounds in excess of 30 mg were of sufficient quantities to use in the three assays.  
Lupeol however did not show any activity. 
The results obtained (Table 2) shows that the reducing powers of all of the compounds 
increased with increasing concentration.  The reducing power of the standard ascorbic acid 
was significantly higher than that of all compounds tested in this assay except for 
uguenenprenol, (8) and 7-O-methylaromadenrin (9), whose values, although lower than 
ascorbic acid were found to be significantly higher than the rest of the compounds tested 
and exhibited good activity even at lower concentrations.  The reducing power of the 
different compounds tested decreased in the following order: uguenenprenol (8) > 7-O-
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methylaromadenrin (9) > 8α, 11-elemodiol (11) > chisocheton (2) > uguenensone (5) = 
flindersiamine (10) > niloticin (1) > limonyl acetate (6) > kihadalactone A (3) > methyl 
uguenenoate (7) > uguenensene (4).  The high antioxidant activity of the flavonoids in 
comparison to the other compounds was expected, since flavonoids are known antioxidants.  
Flavonoids are known to suppress reactive oxygen species formation either by inhibition of 
enzymes or chelating trace elements involved in free radical production, scavenging of 
reactive oxygen species and upregulating or protecting antioxidant defences28.  The presence 
of 3-hydroxyl groups as in compounds 8 and 9 in the heterocyclic ring also increases the 
radical scavenging activity (RSA) 28. 
 
Table 2: Reducing power of compounds from V. uguenensis as evaluated by the FRAP 
method. 
 Absorbance  
Concentration µg/mL   15.6 31.1 62.5 125 250 
Niloticin (1) 0.01±0.00d 0.03±0.00be 0.05±0.00be 0.10±0.01b 0.21±0.00bg 
Chisocheton (2) 0.02±0.01bd 0.03±0.01be 0.06±0.01b 0.11±0.01b 0.27±0.02b 
Kihadalactone A (3)  0.01±0.00d 0.02±0.00e 0.04±0.01ge 0.07±0.00be 0.13±0.00eg 
Uguenensene (4) 0.01±0.01d 0.02±0.00e 0.03±0.00g 0.05±0.00e 0.11±0.00e 
Uguenensone (5) 0.03±0.00b 0.05±0.00bc 0.07±0.00b 0.13±0.00f 0.23±0.00bg 
Limonyl acetate (6) 0.06±0.01c 0.07±0.00c 0.11±0.03f 0.11±0.01f 0.20±0.03be 
Methyl uguenenoate (7) 0.01±0.00d 0.02±0.00e 0.03±0.01g 0.05±0.00e 0.11±0.00e 
Uguenenprenol (8) 0.06±0.01c 0.12±0.00d 0.35±0.02d 0.87±0.00d 1.27±0.10d 
7-O-methylaromadenrin (9) 0.07±0.00c 0.07±0.00c 0.14±0.00c 0.36±0.00c 0.86±0.02c 
Flindersiamine (10) 0.02±0.00bd 0.04±0.00be 0.05±0.01be 0.08±0.00be 0.23±0.02bg 
8α,11-elemodiol (11) 0.03±0.00b 0.04±0.01be 0.05±0.00be 0.10±0.01b 0.28±0.01b 
Ascorbic Acid 0.15±0.02a 0.33±0.06a 0.60±0.01a 1.05±0.01a 1.97±0.15a 
Data are presented as means ±SD of triplicate.  a-gValues  with different superscript letters 
for a given concentration are significantly different from each of the other compounds (One 
way ANOVA followed by Tukey’s multiple range post-hoc test, p < 0.05). 
The RSA results shown in table 3 revealed that the scavenging ability of the novel 
flavonoid, uguenenprenol (8) and 7-O-methylaromadenrin (9) was 94% at 250 µg mL-1.  
Their scavenging effects was marginally higher than that of ascorbic acid in almost all 
concentrations except at the lower concentrations 15.62 µg mL-1 and 31.12 µg mL-1 where 
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ascorbic acid was marginally higher.  Again, the antioxidant activity of the flavonoids 8 and 
9 in this assay were significantly higher than the rest of the compounds.  Of the limonoids 
tested, 2, 5 and 7 displayed significantly higher activities compared to the rest of the 
limonoids.  The RSA of all compounds in decreasing order was: 7-O-methylaromadenrin (9) 
> uguenenprenol (8) > uguenensone (5) > methyl uguenenoate (7) > chisocheton (2) > 
limonyl acetate (6) > uguenensene (4) > flindersiamine (10) > niloticin (1) > 8α,11-
elemodiol (11) > kihadalactone A (3).   
Table 3: Results of the antioxidant activity of compounds isolated from Vepris 
uguenensis as measured by the DPPH method 
 
 Percentage scavenging activity 
Concentrations (µg/mL) 15.6 31.1 62.5 125 250 
Niloticin (1) 2.00±1.00b 8.33±0.58c 12.00±1.00b 14.67±0.58b 22.00±3.61i 
Chisocheton (2) 24.00±1.00i 39.67±0.58h 43.33±0.58e 47.67±1.53d 54.67±1.53h 
Kihadalactone A (3)  1.33±0.58b 6.00±1.00g 9.00±1.00b 11.33±0.58f 13.67±0.58g 
Uguenensene (4) 4.00±2.00h 8.33±1.53c 21.33±1.53c 32.33±2.08e 38.67±4.04f 
Uguenensone (5) 16.00±0.00g 22.00±1.73f 42.00±6.93e 51.33±3.79d 68.00±1.73d 
Limonyl acetate (6) 13.00±1.00f 22.33±0.58f 26.00±1.73f 29.00±1.00e 49.67±0.58e 
Methyl uguenenoate (7) 29.67±2.08d 35.67±1.15e 45.33±2.52e 50.33±0.58d 64.67±0.58d 
Uguenenprenol (8) 41.00±1.00e 72.00±1.00d 87.00±1.00d 91.33±1.53a 93.67±1.53a 
7-O-methylaromadenrin (9) 30.67±0.58d 75.00±2.65d 91.00±1.00d 92.67±1.15a 94.33±0.58a 
Flindersiamine (10) 7.00±0.00c 9.00±1.00c 19.00±1.00c 20.67±0.58c 28.67±2.31c 
8α,11-elemodiol (11) 0.33±0.58b 1.67±0.58b 9.00±1.00b 14.67±2.52b 18.00±1.00b 
Asorbic Acid 37.67±0.58a 78.00±058a 79.67±0.58a 91.00±0.58a 92.67±0.58a 
Data are presented as means ± SD of triplicate.  a-iValues with different superscript letters 
for a given concentration are significantly different from each of the other compounds (One 
way ANOVA followed by Tukey’s multiple range post-hoc test, p < 0.05). 
 
The fact that 2, 5 and 7 have some antioxidant activity in this assay is worth noting as 
limonoids are not common antioxidants.  Due to the low redox potential of flavonoids they 
are thermodynamically able to reduce highly oxidizing free radicals such as superoxide, 
peroxyl, alkoxyl and hydroxyl radicals by hydrogen atom donation28.  Besides scavenging, 
flavonoids may stabilize free radicals involved in oxidative processes by complexing with 
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them 29.  The flavanols containing a catechol group in ring B as in compound 8 and 9 are 
highly active because of the presence of the 3-hydroxyl group.  Additionally, the catechol 
group present in these compounds has strong electron donating properties and target free 
radicals29. 
 
The results of the deoxyribose test are presented in table 4.  The results revealed that the 
hydroxyl radical scavenging activities of the isolated compounds increased with increasing 
concentrations.  As in the other two assays, the highest activity was observed for the 
flavonoids, 8 (77% at 250 µg mL-1) and 9 (83% at 250 µg mL-1) and showed higher activity 
than ascorbic acid at all concentrations.  The sesquiterpenoid (11), and the alkaloid 10, both 
had comparable activities to that of ascorbic acid of 72% and 69% at 250 µg mL-1.  Ascorbic 
acid had an activity of 71% at 250 µg mL-1.  The new limonoid uguenensone (5) exhibited 
an activity of 44% at 15.62 µg mL-1, 50% at 31.25 µg mL-1and 59% at 62.50 µg mL-1, which 
was significantly higher than that of ascorbic acid at the corresponding concentrations, 
however it did not increase at the same rate with increasing concentration as ascorbic acid.  
 
Although flindersiamine (10) and 8α-11-elemodiol (11) did not show high radical 
scavenging activity by the DPPH method, these two compounds showed potency when 
assayed using the deoxyribose method.  Although both of these methods measure hydroxyl 
radical scavenging activity, a plausible explanation for this finding is that these compounds 
(alkaloid and sesquiterpenoid) efficiently target different radicals i.e the DPPH method 
measures the ability to scavenge a phenolic radical whereas the deoxyribose method 
measures the scavenging activity of aliphatic hydroxyl radicals30.  Generally, the scavenging 
activity of the compounds was found to decrease in the order: 7-O-methylaromadenrin (9) > 
uguenenprenol (8) > 8α,11-elemodiol (11) > ascorbic acid > flindersiamine (10) > 
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uguenensone (5) > chisocheton (2) > methyl uguenenoate (7) > limonyl acetate (6) > 
kihadalactone A (3) > niloticin (1) > uguenensene (4).  Higher hydroxyl radical scavenging 
activity in flindersiamine could be attributed to electron rich benzene rings and the double 
bond at ∆2 in the structure which is responsible for electron delocalization upon donation of 
a proton29. 
 
Table 4: Results of the percentage hydroxyl radical scavenging activity of compounds 
from V. uguenensis and ascorbic acid measured by the deoxyribose method. 
 Percentage scavenging activity 
Concentrations (µg/mL) 15.6 31.1 62.5 125 250 
Niloticin (1) 13.33±1.53f 19.67±1.53g 27.00±1.00f 29.00±2.00f 36.67±1.53f 
Chisocheton (2) 34.33±2.52d 40.67±1.53a 43.67±1.53g 47.67±1.53h 55.33±1.53d 
Kihadalactone A (3)  21.33±1.53e 22.67±1.53f 27.00±1.00f 30.00±1.00f 43.33±3.06e 
Uguenensene (4) 5.33±3.06a 11.00±1.00de 19.33±1.53e 21.00±1.00e 34.00±3.61f 
Uguenensone (5) 43.67±2.08c 50.33±1.53c 59.33±1.53c 56.67±1.53g 59.67±2.52d 
Limonyl acetate (6) 3.00±1.00a 12.67±1.15e 20.00±1.00e 32.00±2.00f 45.33±1.53e 
Methyl uguenensoate (7) 5.33±2.08a 10.00±1.00d 14.00±1.00d 22.67±0.58e 53.33±3.06d 
Uguenenprenol (8) 37.33±1.53d 58.00±2.00b 63.33±1.53b 73.00±1.00d 76.67±1.15c 
7-O-Methylaromadenrin (9) 46.00±1.00c 50.33±0.58c 54.67±2.52a 76.33±3.21c 83.00±1.73b 
Flindersiamine (10) 43.00±2.00c 49.67±1.53c 58.67±3.21c 62.00±1.73b 69.00±1.00a 
8α,11-elemodiol (11) 56.67±1.53b 59.00±1.00b 64.67±1.53b 68.33±1.53a 71.67±1.53a 
Asorbic Acid 23.33±1.53a 39.67±1.53a 54.00±1.00a 67.67±0.58a 70.67±1.53a 
Data are presented as means ± SD of triplicate. a-hValues with different superscript letters 
for a given concentration are significantly different from each of the other compounds (One 
way ANOVA followed by Tukey’s multiple range post-hoc test, p < 0.05). 
 
In conclusion, the results of this study show that the classes of compounds and 
concentrations have significant effects on their antioxidant activity.  The flavonoids, as 
expected, showed high activity in all of the antioxidant assays, and in some cases even 
higher than ascorbic acid. Unexpectedly, the limonoids 2, 5 and 7 showed some significant 
antioxidant activity in the DPPH assay and the alkaloid 10 and sesquiterpene 11 showed 
significantly higher activity in the deoxyribose assay compared to many other compounds.  
Whereas the flavonoids are non selective for any particular radical, the limonoids, alkaloids 
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and sesquiterpene may be more selective to certain radicals, hence their activities were not 
consistently observed in all three assays used in this study.  
 
These results provide scientific validity and credence to the ethnomedicinal use of this plant 
in the treatment of malaria as the antioxidants could reduce the ROS linked to cerebral 
malaria in children in Africa.  This study also highlights the efficacy of compounds from V. 
uguenensis as antioxidant additives.  Further to this, the current contribution adds 
uguenensene (4) and uguenensone (5), both of the limonin-type limonoids to the list of 
previously identified Rutaceae limonoids. 
EXPERIMENTAL SECTION 
General Experimental Procedures 
The melting points were recorded on an Ernst Leitz Wetzer micro-hot stage melting point 
apparatus.  Specific rotations were measured at room temperature in chloroform on a 
PerkinElmerTM, Model 341 Polarimeter with a 10 mm flow tube.  UV spectra were 
obtained on a Varian Cary UV-VIS Spectrophotometer.  The Circular Dichroism (CD) 
spectra were recorded on chirascan plus spectropolarimeter by applied photophysics at 
wavelengths 190-400 nm.  IR spectra were recorded on a Perkin-Elmer Universal ATR 
Spectrometer.  The 1H, 13C and all 2D NMR spectra were recorded using a Bruker AvanceIII 
400 MHz spectrometer.  All the spectra were recorded at room temperature using deuterated 
chloroform (CDCl3) as solvent.  High-resolution mass data was obtained using a Bruker 
microTOF-Q II ESI instrument operating at ambient temperatures, with a sample 
concentration of approximately 1 ppm. 
The separation, isolation and purification of compounds were carried out by gravity column 
chromatography and monitored by thin layer chromatography (TLC).  Merck silica gel 60 
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(0.040-0.063 mm) was used for column chromatography and Merck 20 × 20 cm silica gel 60 
F254 aluminum sheets were used for thin-layer chromatography.  
Plant material 
The leaves, stem bark and roots of V. uguenensis were collected from the Rift Valley 
province of Kenya in December 2010 and were identified by Mr Ezekiel Cheboi of the 
Department of Natural Resources, Egerton University, Kenya. A voucher specimen (PKC 
02 NH) was deposited at the Natal Herbarium, Durban. 
Extraction and Isolation 
The air dried powder of V. uguenensis leaves (400 g), stem bark (980 g) and roots (900 g) 
were each sequentially extracted for 24 hours using a soxhlet apparatus with solvents of 
varying polarity; hexane, dichloromethane, ethyl acetate and methanol.  Each extract was 
concentrated using a rotavapor prior to being separated.  The crude extracts were separated 
by column chromatography (CC).  The hexane extract from the leaves (13 g) was separated 
with a hexane: dichloromethane and dichloromethane: ethyl acetate step gradient.  For the 
crude extract, a 4.5 cm diameter column was used and fractions of 100 mL were collected 
and monitored by thin layer chromatography (TLC).  Fractions with similar TLC profiles 
were combined.  From this column separation, eleven fractions (A-K) were obtained.  
Fraction C was recrystallised in methanol to yield lupeol (118 mg) while fraction G was 
purified using hexane: dichloromethane (7:3) to afford three subfractions G1-G3 of which 
subfraction G3 yielded 8α,11-elemodiol (11) (59 mg).  Fraction H was purified using 
hexane: EtOAc (8:2) to yield subfractions, H1-H4 of which subfraction H4 was washed 
several times with hexane to yield niloticin (1) (583 mg).  Fraction J was purified with 
100% dichloromethane and then EtOAc: dichloromethane (1:4) to afford five subfractions, 
J1-J5.  Subfraction J3 contained chisocheton (2) (83 mg) while subfraction J5 was purified 
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further using dichloromethane: EtOAc (9:1) to give limonyl acetate (6) (134 mg).  The 
dichloromethane extract of the leaves (9 g) was also separated using a hexane: EtOAc and 
EtOAc: methanol step gradient from 100% hexane to 1:4 (methanol: EtOAc) to give 9 
fractions (A-I).  Fraction E was purified with hexane: EtOAc (4:1) to afford 7-O-
methylaromadenrin (9) (51 mg), while fraction G was purified using hexane: 
dichloromethane (1:1) to give four subfractions G1-G4 of which fraction G2 was further 
purified with 100% dichloromethane to yield uguenensone  (5) (92 mg).  Fraction H was 
purified with dichloromethane: EtOAc (4:1) to give uguenenprenol (8) (38 mg). 
The hexane extract (32 g) from the stems yielded the same compounds as the hexane extract 
of the leaves.  The dichloromethane extract of the stems (15 g) was eluted with a hexane: 
EtOAc and EtOAc: methanol step gradient starting from 100% hexane and stepped up to 
100% EtOAc and then to 10% MeOH in EtOAc to give nine fractions A-I.  Fraction H was 
purified with hexane: EtOAc (6:4) to give five subfractions H1-H5.  Subfraction H2 was 
further purified using dichloromethane: EtOAc (4:1) to yield uguenensene (4) (241 mg).  
Subfraction H1 was purified with dichloromethane: EtOAc (4:1) into four other subfractions 
H1a-H1d. Fraction H1a yielded tricoccin S13 acetate (23 mg) with 100% dichloromethane.  
Fraction H1c was purified using dichloromethane: EtOAc (7:3) to afford three fractions after 
combination, H1ca-H1cc. Kihadalactone (3) (117 mg) was contained in fraction H1ca while 
methyl uguenenoate (7) (120 mg) was obtained in fraction H1cc.  
The dichloromethane extract from the roots was separated with hexane: EtOAc and then 
EtOAc: MeOH.  More methyl uguenenoate (7) was obtained after purification of fraction D 
with dichloromethane: EtOAc (4:1) and the two alkaloids skimmianine and flindersiamine 
(10) were contained in fraction H.  Their separation was achieved after repeated column 
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chromatography using dichloromethane: EtOAc (1:1), where fraction H2c yielded 
skimmianine (13 mg) and H2d yielded flindersiamine (10) (45 mg). 
Compound 4: Reddish brown; mp 105-109 oC; [α]20D -62.50 (c 0.056 CHCl3); UV (CHCl3) 
λmax (log ε) 240 (1.28) nm; CD (CH3CN) λmax (∆ε) 197 (+8.5), 210 (-22.0), 328 (+1.2) nm; 
IR νmax 2926, 1733, 1370, 1231, 1031, 729 cm
-1; 1H NMR and 13C NMR data: see Table 1; 
EIMS m/z (rel. int.) 484 [M]+ (33), 469 (10), 441 (10), 424 (100), 409 (88), 347 (50), 330 
(68); HREIMS m/z 484.2324 [M]+ (calcd. for C28H36O7, 484.2461). 
Compound 5: Dark brown solid; mp 132-134 oC; [α]20D -14.85 (c 0.404, CHCl3); 
UV(CHCl3) λmax (log ε) 246 (0.72) nm; CD (CH3CN) λmax (∆ε) 197 (+8.5), 210 (-22.0), 328 
(+1.2) nm ; IR νmax 2960, 1732, 1369, 1230, 1028, 726 cm
-1; 1H NMR and 13C NMR data: 
see Table 1; EIMS m/z (rel. int.)  498 [M]+ (100), 482 (25), 467 (25), 438 (38), 423 (50), 
384 (38), HREIMS 498.9120 [M]+ (calcd. for C28H34O8, 498.5648).  
Compound 8: Light yellow crystals; mp 75-78 oC; [α]20D +52.30 (c 0.056 CHCl3); UV 
(CHCl3) λmax (log ε) 337 (4.45), 285 (5.13), 239 (5.44) nm; CD (CH3CN) λmax (∆ε) 205 
(+8.8), 290 (+4.0), 335 (+2.0) nm; IR νmax 3330, 2924, 1708, 1634 cm
-1; 1H NMR (CD3OD, 
400 MHz) δ 7.36 (2H, d, J = 8.56 Hz, H-2’/6’), 6.85 (2H, d, J = 8.56 Hz, H-3’/5’), 6.09 (1H, 
d, J = 2.20 Hz, H-6), 6.04 (1H, d, J = 2.20 Hz, H-8), 5.70 (1H, t, J = 6.32 Hz, H-2’’), 4.82 
(1H, d, J = 11.65 Hz, H-2), 4.66 (2H, d, J = 6.32 Hz, 2H-1’’), 4.58 (1H, d, J = 11.65 Hz, H-
3), 3.76 (2H, s, H-4’’), 1.54 (3H, s, H-5’’); 13C NMR (CD3OD, 100 MHz) δ 198.98 (C, C-
4), 168.97 (C, C-7), 165.01 (C, C-5), 164.36 (C, C-4’), 159.28 (C, C-9), 142.04 (C, C-3’’), 
130.40 (2CH, C-2’/6’),  129.16 (C, C-1’), 119.65 (CH, C-2’’), 116.18 (2CH, 3’/5’), 102.61 
(C, C-10), 96.71 (CH, C-6), 95.64 (CH, C-8), 85.10 (CH, C-2), 73.72 (CH, C-3), 67.63 
(CH2, C-4’’), 66.25 (CH2, C-1’’),  14.03 (CH3, C-5’’); HREIMS  m/z 372.1158 [M]
+ (calcd. 
for C20H20O7, 372.1209). 
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ANTIOXIDANT ACTIVITY 
Determination of the reducing potential using the Ferric Reducing Antioxidant Power 
(FRAP) assay  
The total reducing power of each compound from Vepris uguenensis was determined 
according to the Ferric Reducing Antioxidant Power (FRAP) method as described31.  A 2.5 
mL volume of different concentrations of the compounds (250, 125, 62.5, 31.25 and 15.625 
µg mL-1) were mixed with 2.5 mL phosphate buffer solution (0.2 M, pH = 6.6) and 2.5 mL 
of 1% potassium ferriccyanide [K3Fe(CN)6] in test tubes.  The mixture was placed in a 
water bath of 50 oC, for 20 minutes.  A volume of 2.5 mL of 10% trichloroacetic acid (TCA) 
was added to the mixture and mixed thoroughly.  A volume of 2.5 mL of this mixture was 
then mixed with 2.5 mL distilled water and 0.5 mL FeCl3 of 0.1% solution and allowed to 
stand for 10 min.  The absorbance of the mixture was measured at 700 nm using a UV-VIS 
spectrophotometer (UV mini 1240, Shimadzu Corporation, Kyoto, Japan); the higher the 
absorbance of the reaction mixture, the greater the reducing power.  Ascorbic acid was used 
as a positive control for this assay.  All procedures were performed in triplicate. 
Measurement of free radical scavenging activity using the DPPH assay 
The free radical scavenging activity (antioxidant capacity) of the plant phytochemicals on 
the stable radical, 2,2-diphenyl-β-picrylhydrazyl (DPPH) was evaluated by the method 
established by Shirwaikar et al.32.  In this assay, a volume of 1.5 mL of methanolic solution 
of the compound at different concentrations was mixed with 0.5 mL of the methanolic 
solution of DPPH (0.1 mM).  An equal amount of methanol and DPPH without sample 
served as a control.  After 30 minutes of reaction at room temperature in the dark, the 
absorbance was measured at 517 nm against methanol as a blank using a UV 
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spectrophotometer as mentioned above.  The percentage free radical scavenging activity was 
calculated according to the following equation: 
% Scavenging activity = [(Ac-As) / Ac] × 100  
Where Ac = Absorbance of control and As = Absorbance of sample  
 
Determination of hydroxyl radical scavenging activity using the Deoxyribose assay 
The deoxyribose assay for hydroxyl radical scavenging activity was performed as described 
previously by Chung et al.33.  A mixture of 2-deoxyribose (5.6 mM, 500 µL), Fe3+ chloride 
(0.1 mM, 100 µL) and EDTA (0.1 mM, 100 µL), H2O2 (1 mM, 100 µL), 100 µL of sample 
(concentrations ranging from 15.625 to 250 µg/mL), 500 µL of 50 mM potassium phosphate 
buffer (pH 7.4) and 100 µL of vitamin C (1 mM) was made and incubated for 30 min at 50 
°C. The Fe3+ chloride and EDTA was mixed prior to combining the other reagents.  A 
solution of thiobarbituric acid (TBA) (1 mL, 1% w/v) and trichloroacetic acid (TCA) in 
aqueous solution (1 mL, 2.8% w/v) was added, and the mixture was heated for 30 minutes 
in a water bath at 50 oC. The absorbance of the amount of chromogen produced was 
measured at 532 nm using a UV spectrophotometer as mentioned above.  The hydroxyl 
radical scavenging activity (percentage inhibition rate) was calculated according to the 
equation as follows:  
% Scavenging activity = [(Ac-As) / Ac] × 100   
Where Ac = Absorbance of control and As = Absorbance of sample 
All experiments were performed in triplicate. 
 
Statistical Analysis  
The data are presented as mean ± SD of triplicates.  The data were statistically analyzed by 
using a statistical software program SPSS (SPSS for windows, version 18, SPSS Science, 
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Chicago, IL, USA).  The one-way analysis of variance (ANOVA) followed by the Tukey’s 
multiple range post-hoc test was employed to find the differences.  The data were 
considered significantly different at p < 0.05. 
 
ASSOCIATED CONTENT 
Supporting Information  
1D and 2D NMR spectra of compounds 5, 6 & 9 are available free of charge via the internet 
at http://pubs.acs.org.   
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CHAPTER SEVEN 
SUMMARY AND CONCLUSION 
7.1 Summary  
This study focused on the isolation and characterisation of secondary metabolites from four 
plants belonging to the genera Vernonia and Vepris which are used in Kenyan traditional 
medicine as an analgesic, antibacterial, antimalarial, anti-allergy medication, and antivenom 
(snake bite) and for dermatological infection, dental caries, respiratory tract infections, eye 
problems, cardiovascular complications, neurological disorders and psychotic disorders.  
The study was undertaken in order to validate the use of these plants in what they are being 
traditionally used for as well as to provide the traditional healers with a scientific basis for 
using the plants to treat additional medical symptoms and diseases. 
In order to do this, the plants were investigated for their phytochemical constituents and 
based on what was present, a literature search on the medicinal properties of the compounds 
were undertaken to provide a rationale for the use of the plants in different medicinal areas.  
In addition, bioassays were identified to test the activity of the isolated compounds, thereby 
providing additional information on the use of the plant in traditional medicine. 
7.1.1 Recommendations for Vernonia auriculifera 
Vernonia auriculifera is used in Kenyan traditional medicine for the treatment of headache, 
conjunctivitis, toothache, snake bite and bacterial infection (wound infection).  Previous 
phytochemical studies have found hydroperoxides of unsaturated fatty acid methyl esters 
and plant growth stimulators from V. auriculifera leaves.  Our studies have revealed the 
leaves to contain a sesquiterpene amine (farnesylamine), four triterpenoids, (lupenyl acetate, 
α-amyrin, β-amyrin and β-amyrin acetate) and a steroid (β-sitosterol).  The stem bark 
 
P a g e  | 153 
afforded two triterpenoids, friedelanone and friedelin acetate.  From the roots, one 
triterpenoid, oleanolic acid was isolated.  The triterpenoids have been reported to be used as 
antibacterials, antifungals, anti-inflammatories, anti-leishmanials and antimalarials.  The 
plant could therefore be used in traditional medicine to treat the symptoms of inflammation 
and infections by bacteria, fungus and parasites (malaria and leishmania).  
In addition we have tested the compounds for antibacterial and antibiofilm activities using 
the broth microdilution method and found that β-amyrin, α-amyrin and β-amyrin acetate 
had moderate antibacterial activity.  At sub-MIC concentrations, oleanolic acid and β-
amyrin acetate exhibited antibiofilm activity.  Due to the inavailability of health facilities 
and expensive pharmaceutical supplies in most of rural Kenya, the plant V. auriculifera 
could replace common commercial antibiotics.   
The isolation of pentacyclic triterpenoids in V. auriculifera also provides a chemotaxonomic 
link to the genus Vernonia as pentacyclic triterpenoids could be an additional 
chemotaxanomic marker to the sesquiterpene lactones. 
7.1.2 Recommendations for Vernonia urticifolia 
Vernonia urticifolia is used in Kenyan traditional medicine for the treatment of sinuses, 
allergy, respiratory tract infection and skin infections.  There are no previous phytochemical 
or pharmacological studies carried out on this plant.  Our studies have indicated the leaves 
to contain, a polyene, urticifolene, a carotenoid and a streroid, β-sitosterol.  Polyenes are 
known to be used as anti-fungal agents and carotenoids are known to have antibacterial, 
anticancer and antioxidant properties.  The plant could therefore be used in traditional 
medicine to treat the symptoms of bacterial infections, fungal infections and cancer.  It can 
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also be used as an antioxidant supplement due to its carotenoid component which are 
reported to be antioxidants. 
We assesed the compounds for antibacterial activity using the broth microdilution methods 
and found that lutein and urticifolene possessed antibacterial activity.  This plant could 
substitute/supplement modern antibiotics in most of rural Kenya where modern health 
facitilities are inaccessible.  The compounds isolated from V. urticifolia add to the existing 
compounds from the genus Vernonia.  
7.1.3 Recommendations for Vepris glomerata 
Vepris glomerata is used in Kenyan traditional medicine for the treatment of malaria, eye 
problem, cardiac pain, epilepsy, stroke and psychosis.  Previous phytochemical studies have 
found the leaves of the plant to contain two furoquinoline alkaloids, skimmianine and 
(montrifoline) evoxine.  
 
Our studies have indicated the leaves to contain a flavonoid (veprisinol) and four 
furoquinoline alkaloids, haplopine-3,3’-dimethylallyl ether, anhydroevoxine, evoxine, and 
skimmianine.  The stem bark was found to contain two cinnamic acid derivatives, (p-
hydroxycinnamic acid and caffeic acid), an aromatic ester (methyl caffeate), a flavonoid 
(hesperetin) and two limonoids (limonin and limonyl acetate).  The roots contained a 
cinnamaldehyde derivative (glomeral), a coumarin (scoparone) and a lignin (syringaresinol).  
Surpringly most of this compounds are derived from cinnamic acids, a key intermediate in 
the shikimate and phenylpropanoid pathways where these classes of compounds are 
biosynthesized.  Cinnamic acids have been known to possess a wide range of biological 
activities such as anti TB, antidiabetic, antioxidant, antimicrobial, hepatoprotective, CNS 
depressant, anticholesterolemic, antifungal, antihyperglycemic, antimalarial, antiviral, cytotoxic, 
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anti-inflammatory as well as to absorb UV rays.  Flavonoids have been known to be used as 
antioxidants while alkaloids are reported to possess antimicrobial, antiradical, antioxidant, 
antiplasmodial, anticancer, and antimutagenic activities.  Limonoids are reported to exhibit 
antifungal, antibacterial, antimalarial, antiprotozoan, antiviral, anti-inflammatory and 
antioxidant activities.  
 
The parts of this plant could therefore be used in traditional medicine to treat a wide range 
of diseases including; the symptoms of malaria, bacterial and fungal infection, cancer, 
diabetes, TB and inflammation and could also be taken as an antioxidant supplement due to 
its flavonoid component.  
 
In addition we have tested the flavonoids and alkaloids for antioxidant activity using the 
DPPH, FRAP and deoxyribose methods and found that two of the compounds were even 
more active than ascorbic acid as an antioxidant in the deoxyribose test. Compounds 
isolated from the stem bark and roots were also assessed for antibacterial activity using the 
disc diffusion and broth microdilution methods. Glomeral and hesperetin were found to be 
active.  Due to the inaccessibility of pharmaceutical supplies in most of rural Kenya, V. 
glomerata could replace common commercial antibiotics and antioxidants such as vitamin C 
in these communities. 
Since veprisinol and haplopine-3, 3’-dimethylallyl ether shows high antioxidant activity 
whereas glomeral exhibited good antibacterial activity, further work is necessary to first 
investigate a possible synthetic scheme for the synthesis of these compounds and then 
determine whether veprisinol and haplopine-3, 3’-dimethylallyl ether can be developed into 
a commercial antioxidant supplement.  Glomeral can be developed into a commercial 
antibiotic in the face of rising bacterial resistance 
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The isolation of limonin-type limonoids in V. glomerata also provides a chemotaxonomic 
link to the family Rutaceae as this class of limonoids are exclusive to members of the family 
Rutaceae.  The isolation of furoquinoline alkaloids provides a chemotaxonomic link to the 
genus Vepris. 
7.1.4 Recommendations for Vepris uguenensis 
Vepris uguenensis is used in Kenyan traditional medicine for the treatment of malaria 
Previous phytochemical studies have found the root bark of this plant to contain methyl 
uguenenoate, uguenenazole, uguenenonamide, flindersiamine, maculosidine and 
syringaldehyde.  Our studies have indicated the leaves to contain a triterpenoid (lupeol), two 
protolimonoids (niloticin and chisocheton), limonoids (uguenensone and limonyl acetate), 
flavonoids (uguenenprenol and 7-O-methylaromadenrin) and sesquiterpenoid, 8α,11-
elemodiol.  The stem bark contained the protolimonoid (chisocheton) limonoids 
(kihadalactone A, uguenensene and tricoccin S13 acetate) and a furoquinoline alkaloid, 
(skimmianine) and the roots were found to contain a limonoid (methyl uguenenoate) and 
furoquinoline alkaloid, flindersiamine.  Alkaloids, flavonoids and limonoids have a wide 
range of biological activities as discussed above (section 7.3). 
 
V. uguenensis could therefore be used in traditional medicine to treat the symptoms of 
malaria, inflammation, bacterial, viral and fungal infections and could also be taken as an 
antioxidant supplement due to its flavonoid component. 
 
Since uguenenprenol and 7-O-methylaromadenrin shows high antioxidant activity, further 
work is necessary to investigate the synthesis of these compounds and then develop these 
flavonoids into commercial antioxidant supplements. 
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The isolation of six limonoids of in V. uguenensis also provides a chemotaxonomic link to 
the family Rutaceae as this class of limonoids are common to members of the family 
Rutaceae and rare in other limonoid producing families such as the Meliaceae family.  The 
limonoids and the protolimonoids isolated, altogether formed an interesting limonin 
biosynthetic pathway.  The isolation of uguenensene and uguenensone provided the missing 
compounds in this biosynthetic scheme. 
7.2 Conclusion 
The two Vernonia and Vepris species studied in this work produced a range of secondary 
metabolites, which have shown to have pharmaceutical effects, both in the literature and by 
our own bioassays.  This knowledge is important for the ethnomedicinal healers in that they 
could use this as a rationale for using the plants in African traditional medicine.  
Furthermore, these plants provide an inexpensive alternative to the pharmaceuticals already 
on the market, which in many cases is inaccessible to the local communities in Kenya. 
Our work has shown, in particular that these plants could be used as antioxidant 
supplements and antibacterial agents.  It is worthwhile to take selected molecules which are 
highly active from these results and test them in suitable animal modes. Further to this it 
would also be important to test both the extracts and the active isolates for cytotoxicity to 
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SUPPORTING INFORMATION 
Supporting information includes 1D NMR, 2D NMR, IR, UV, MS and CD experiments. 
Chapter 2: Lupenyl acetate P1-1, oleanolic acid P1-2, β-amyrin & α-amyrin P1-3 &5, 
β-amyrin acetate P1-4, friedelanone P1-6, friedelin acetate P1-7, β-sitosterol 
P1-8 and farnesylamine P1-9. 
Chapter 3: Urticifolene P2-1 and lutein P2-2. 
Chapter 4: Veprisinol P3-1, isohaplopine-3,3’-dimethylallyl ether P3-2, tecleoxine P3-3, 
nkolbisine P3-4 and skimmianine P3-5. 
Chapter5: Glomeral P4-1, p-hydroxycinnamic acid P4-2, caffeic acid P4-3, methyl 
caffeate P4-4, hesperetin P4-5, scoparone P4-6, syringaresinol P4-7, limonin 
P4-8 and limonyl acetate P4-9. 
Chapter 6: Niloticin P5-1, chisocheton P5-2, kihadalactone A P5-3, uguenensene P5-4, 
uguenensene P5-5, methyl uguenensoate P5-6, uguenenprenol P5-7, 7-O-
methylaromadenrin P5-8, flindersiamine P5-9, 8α,11-elemodiol P5-10, 
tricoccin S13 acetate P5-11 and lupeol P5-12. 
 
 
 
 































































































































































































































































































































































































































































